Document and Entity Information - shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Apr. 17, 2019 |
|
| Document Type | 10-Q | |
| Amendment Flag | false | |
| Entity Small Business | false | |
| Entity Emerging Growth Company | false | |
| Document Period End Date | Mar. 31, 2019 | |
| Document Fiscal Year Focus | 2019 | |
| Document Fiscal Period Focus | Q1 | |
| Trading Symbol | AFL | |
| Entity Registrant Name | Aflac Incorporated | |
| Entity Central Index Key | 0000004977 | |
| Current Fiscal Year End Date | --12-31 | |
| Entity Filer Category | Large Accelerated Filer | |
| Entity Common Stock, Shares Outstanding | 745,469,119 |
Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Statement of Comprehensive Income [Abstract] | ||
| Net earnings | $ 928 | $ 717 |
| Other comprehensive income (loss) before income taxes: | ||
| Unrealized foreign currency translation gains (losses) during period | (1) | 824 |
| Unrealized gains (losses) on fixed maturity securities: | ||
| Unrealized holding gains (losses) on fixed maturity securities during period | 3,196 | (1,931) |
| Reclassification adjustment for realized (gains) losses on fixed maturity securities included in net earnings | (17) | (2) |
| Unrealized gains (losses) on derivatives during period | (3) | 6 |
| Pension liability adjustment during period | 7 | (3) |
| Total other comprehensive income (loss) before income taxes | 3,182 | (1,106) |
| Income tax expense (benefit) related to items of other comprehensive income (loss) | 852 | (763) |
| Other comprehensive income (loss), net of income taxes | 2,330 | (343) |
| Total comprehensive income (loss) | $ 3,258 | $ 374 |
Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Thousands, $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
||
|---|---|---|---|---|
| Available for sale, fixed maturity securities, amortized cost | $ 78,706 | $ 76,856 | ||
| Held to maturity, fixed maturity securities, fair value | 37,446 | 36,722 | ||
| Commercial mortgage and other loans | 7,180 | 6,919 | ||
| Other investments | $ 1,238 | $ 787 | ||
| Common stock, par value (in dollars per share) | $ 0.10 | $ 0.10 | ||
| Common stock, shares authorized (in shares) | 1,900,000 | 1,900,000 | ||
| Common stock, shares issued (in shares) | 1,348,600 | 1,347,540 | ||
| Variable Interest Entity, Consolidated | ||||
| Available for sale, fixed maturity securities, amortized cost | $ 3,756 | $ 3,849 | ||
| Commercial mortgage and other loans | 5,892 | 5,528 | ||
| Other investments | [1] | 374 | 328 | |
| Consolidated Entity Excluding Variable Interest Entities (VIE) | ||||
| Available for sale, fixed maturity securities, amortized cost | $ 74,950 | $ 73,007 | ||
| ||||
Consolidated Statements of Shareholders' Equity - USD ($) $ in Millions |
Total |
Common stock |
Additional paid-in capital |
Retained earnings |
Accumulated other comprehensive income (loss) |
Treasury stock |
|||
|---|---|---|---|---|---|---|---|---|---|
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
| Cumulative effect of change in accounting principle, net of income taxes | [1] | $ 0 | $ 0 | $ 0 | $ (226) | $ 226 | $ 0 | ||
| Balance, beginning of period at Dec. 31, 2017 | 24,598 | 135 | 2,052 | 29,895 | 4,028 | (11,512) | |||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
| Net earnings | 717 | 0 | 0 | 717 | 0 | 0 | |||
| Unrealized foreign currency translation gains (losses) during period, net of income taxes | 447 | 0 | 0 | 0 | 447 | 0 | |||
| Unrealized gains (losses) on fixed maturity securities during period, net of income taxes and reclassification adjustments | [1] | (984) | 0 | 0 | 0 | (984) | 0 | ||
| Unrealized gains (losses) on derivatives during period, net of income taxes | 2 | 0 | 0 | 0 | 2 | 0 | |||
| Pension liability adjustment during period, net of income taxes | (34) | 0 | 0 | 0 | (34) | 0 | |||
| Dividends to shareholders | (203) | 0 | 0 | (203) | 0 | 0 | |||
| Exercise of stock options | 14 | 0 | 14 | 0 | 0 | 0 | |||
| Share-based compensation | 10 | 0 | 10 | 0 | 0 | 0 | |||
| Purchases of treasury stock | (309) | 0 | 0 | 0 | 0 | (309) | |||
| Treasury stock reissued | 29 | 0 | 13 | 0 | 0 | 16 | |||
| Balance, end of period at Mar. 31, 2018 | 24,287 | 135 | 2,089 | 30,183 | 3,685 | (11,805) | |||
| Balance, beginning of period at Dec. 31, 2018 | 23,462 | 135 | 2,177 | 31,788 | 2,151 | (12,789) | |||
| Increase (Decrease) in Stockholders' Equity [Roll Forward] | |||||||||
| Net earnings | 928 | 0 | 0 | 928 | 0 | 0 | |||
| Unrealized foreign currency translation gains (losses) during period, net of income taxes | (1) | 0 | 0 | 0 | (1) | 0 | |||
| Unrealized gains (losses) on fixed maturity securities during period, net of income taxes and reclassification adjustments | 2,327 | 0 | 0 | 0 | 2,327 | 0 | |||
| Unrealized gains (losses) on derivatives during period, net of income taxes | (2) | 0 | 0 | 0 | (2) | 0 | |||
| Pension liability adjustment during period, net of income taxes | 6 | 0 | 0 | 0 | 6 | 0 | |||
| Dividends to shareholders | (203) | 0 | 0 | (203) | 0 | 0 | |||
| Exercise of stock options | 11 | 0 | 11 | 0 | 0 | 0 | |||
| Share-based compensation | 8 | 0 | 8 | 0 | 0 | 0 | |||
| Purchases of treasury stock | (517) | 0 | 0 | 0 | 0 | (517) | |||
| Treasury stock reissued | 30 | 0 | 12 | 0 | 0 | 18 | |||
| Balance, end of period at Mar. 31, 2019 | $ 26,049 | $ 135 | $ 2,208 | $ 32,513 | $ 4,481 | $ (13,288) | |||
| |||||||||
Consolidated Statements of Shareholders' Equity (Parenthetical) - $ / shares |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Retained earnings | ||
| Dividends to shareholders (in dollars per share) | $ 0.27 | $ 0.26 |
Consolidated Statements of Cash Flows - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Cash flows from operating activities: | ||
| Net earnings | $ 928 | $ 717 |
| Adjustments to reconcile net earnings to net cash provided by operating activities: | ||
| Change in receivables and advance premiums | 35 | 14 |
| Capitalization of deferred policy acquisition costs | (357) | (349) |
| Amortization of deferred policy acquisition costs | 340 | 314 |
| Increase in policy liabilities | 468 | 572 |
| Change in income tax liabilities | 316 | (131) |
| Realized investment (gains) losses | (71) | 134 |
| Other, net | (115) | (33) |
| Net cash provided (used) by operating activities | 1,544 | 1,238 |
| Proceeds from investments sold or matured: | ||
| Available-for-sale fixed maturity securities | 760 | 943 |
| Equity securities | 153 | 157 |
| Held-to-maturity fixed maturity securities | 155 | 50 |
| Commercial mortgage and other loans | 493 | 146 |
| Costs of investments acquired: | ||
| Available for sale fixed maturity securities | (2,548) | (3,975) |
| Equity securities | (151) | (166) |
| Commercial mortgage and other loans | (669) | (1,772) |
| Other investments, net | (442) | (125) |
| Settlement of derivatives, net | (3) | (1) |
| Cash received (pledged or returned) as collateral, net | 976 | 4,578 |
| Other, net | (15) | (34) |
| Net cash provided (used) by investing activities | (1,291) | (199) |
| Cash flows from financing activities: | ||
| Purchases of treasury stock | (490) | (296) |
| Proceeds from borrowings | 0 | 2 |
| Dividends paid to shareholders | (195) | (195) |
| Change in investment-type contracts, net | (13) | 7 |
| Treasury stock reissued | 12 | 14 |
| Other, net | 0 | (5) |
| Net cash provided (used) by financing activities | (686) | (473) |
| Effect of exchange rate changes on cash and cash equivalents | (12) | 23 |
| Net change in cash and cash equivalents | (445) | 589 |
| Cash and cash equivalents, beginning of period | 4,337 | 3,491 |
| Cash and cash equivalents, end of period | 3,892 | 4,080 |
| Supplemental disclosures of cash flow information: | ||
| Income taxes paid | (2) | 396 |
| Interest paid | 36 | 36 |
| Noncash interest | 22 | 21 |
| Impairment losses included in realized investment losses | 2 | 7 |
| Noncash financing activities: | ||
| Lease obligations | 1 | 1 |
| Associate stock bonus | ||
| Treasury stock issued for: | ||
| Treasury stock issued | 6 | 5 |
| Shareholder dividend reinvestment | ||
| Treasury stock issued for: | ||
| Treasury stock issued | 8 | 8 |
| Share-based compensation grants | ||
| Treasury stock issued for: | ||
| Treasury stock issued | $ 4 | $ 2 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Description of Business Aflac Incorporated (the Parent Company) and its subsidiaries (collectively, the Company) primarily sell supplemental health and life insurance in the United States and Japan. The Company's insurance business is marketed and administered through American Family Life Assurance Company of Columbus (Aflac) in the United States and, effective April 1, 2018, through Aflac Life Insurance Japan Ltd. (ALIJ) in Japan. Prior to April 1, 2018, the Company's insurance business was marketed in Japan as a branch of Aflac. The Company’s operations consist of two reportable business segments: Aflac U.S., which includes Aflac, and Aflac Japan, which includes ALIJ. American Family Life Assurance Company of New York (Aflac New York) is a wholly owned subsidiary of Aflac. Most of Aflac's policies are individually underwritten and marketed through independent agents. Additionally, Aflac U.S. markets and administers group products through Continental American Insurance Company (CAIC), branded as Aflac Group Insurance. The Company's insurance operations in the United States and Japan service the two markets for the Company's insurance business. Aflac Japan's revenues, including realized gains and losses on its investment portfolio, accounted for 68% and 71% of the Company's total revenues in the three-month periods ended March 31, 2019 and 2018, respectively. The percentage of the Company's total assets attributable to Aflac Japan was 84% at March 31, 2019 and December 31, 2018, respectively. Basis of Presentation The Company prepares its financial statements in accordance with U.S. generally accepted accounting principles (U.S. GAAP). These principles are established primarily by the Financial Accounting Standards Board (FASB). In these Notes to the Consolidated Financial Statements, references to U.S. GAAP issued by the FASB are derived from the FASB Accounting Standards CodificationTM (ASC). The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates based on currently available information when recording transactions resulting from business operations. The most significant items on the Company's balance sheet that involve a greater degree of accounting estimates and actuarial determinations subject to changes in the future are the valuation of investments and derivatives, deferred policy acquisition costs (DAC), liabilities for future policy benefits and unpaid policy claims, and income taxes. These accounting estimates and actuarial determinations are sensitive to market conditions, investment yields, mortality, morbidity, commission and other acquisition expenses, and terminations by policyholders. As additional information becomes available, or actual amounts are determinable, the recorded estimates will be revised and reflected in operating results. Although some variability is inherent in these estimates, the Company believes the amounts provided are adequate. The unaudited consolidated financial statements include the accounts of the Parent Company, its subsidiaries and those entities required to be consolidated under applicable accounting standards. All material intercompany accounts and transactions have been eliminated. In the opinion of management, the accompanying unaudited consolidated financial statements of the Company contain all adjustments, consisting of normal recurring accruals, which are necessary to fairly present the consolidated balance sheets as of March 31, 2019, and December 31, 2018, the consolidated statements of earnings and comprehensive income (loss), shareholders' equity and cash flows for the three-month periods ended March 31, 2019 and 2018. Results of operations for interim periods are not necessarily indicative of results for the entire year. As a result, these financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2018 (2018 Annual Report). Reclassifications: Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on net earnings or total shareholders' equity. New Accounting Pronouncements Recently Adopted Accounting Pronouncements
Accounting Pronouncements Pending Adoption
Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company's business. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BUSINESS SEGMENT INFORMATION |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BUSINESS SEGMENT INFORMATION | BUSINESS SEGMENT INFORMATION The Company consists of two reportable insurance business segments: Aflac Japan and Aflac U.S., both of which sell supplemental health and life insurance. In addition, operating business units that are not individually reportable and business activities, including reinsurance retrocession activities, not included in Aflac Japan or Aflac U.S. are included in Corporate and other. The Company does not allocate corporate overhead expenses to business segments. Consistent with U.S. GAAP accounting guidance for segment reporting, the Company evaluates and manages its business segments using a financial performance measure called pretax adjusted earnings. Adjusted earnings are adjusted revenues less benefits and adjusted expenses. The adjustments to both revenues and expenses account for certain items that cannot be predicted or that are outside management’s control. Adjusted revenues are U.S. GAAP total revenues excluding realized investment gains and losses, except for amortized hedge costs/income related to foreign currency exposure management strategies and net interest cash flows from derivatives associated with certain investment strategies. Adjusted expenses are U.S. GAAP total acquisition and operating expenses including the impact of interest cash flows from derivatives associated with notes payable but excluding any nonrecurring or other items not associated with the normal course of the Company’s insurance operations and that do not reflect Aflac’s underlying business performance. The Company excludes income taxes related to operations to arrive at pretax adjusted earnings. Information regarding operations by reportable segment and Corporate and other, follows:
(1) Amortized hedge costs of $62 and $55 for the three-month periods ended March 31, 2019, and 2018, respectively, related to certain foreign currency exposure management strategies have been reclassified from realized investment gains (losses) and reported as a deduction from net investment income when analyzing operations. (2) Amortized hedge income of $20 and $2 for the three-month periods ended March 31, 2019, and 2018, respectively, related to certain foreign currency exposure management strategies has been reclassified from realized investment gains (losses) and reported as an increase to net investment income when analyzing operations. (3) Net interest cash flows from derivatives associated with certain investment strategies of $(7) for the three-month period ended March 31, 2019 and an immaterial amount in 2018, respectively, have been reclassified from realized investment gains (losses) and included in adjusted earnings as a component of net investment income.
(1) Amortized hedge costs of $62 and $55 for the three-month periods ended March 31, 2019, and 2018, respectively, related to certain foreign currency management strategies have been reclassified from realized investment gains (losses) and reported as a deduction from pretax adjusted earnings when analyzing operations. (2) Amortized hedge income of $20 and $2 for the three-month periods ended March 31, 2019, and 2018, respectively, related to certain foreign currency management strategies has been reclassified from realized investment gains (losses) and reported as an increase in pretax adjusted earnings when analyzing operations. (3) Net interest cash flows from derivatives associated with certain investment strategies of $(7) for the three-month period ended March 31, 2019 and an immaterial amount in 2018, respectively, have been reclassified from realized investment gains (losses) and included in adjusted earnings as a component of net investment income. (4) A gain of $17 and $17 for the three-month periods ended March 31, 2019, and 2018, respectively, related to the interest rate component of the change in fair value of foreign currency swaps on notes payable have been reclassified from realized investment gains (losses) and included in adjusted earnings when analyzing operations
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVESTMENTS |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| INVESTMENTS | INVESTMENTS Investment Holdings The amortized cost for the Company's investments in fixed maturity securities, the cost for equity securities and the fair values of these investments are shown in the following tables.
The methods of determining the fair values of the Company's investments in fixed maturity securities and equity securities are described in Note 5. During the first quarter of 2019 and 2018, respectively, the Company did not reclassify any investments from the held-to-maturity category to the available-for-sale category. Contractual and Economic Maturities The contractual and economic maturities of the Company's investments in fixed maturity securities at March 31, 2019, were as follows:
Economic maturities are the expected maturity date created by the combination of features in the financial instrument. Expected maturities may differ from contractual maturities because some issuers have the right to call or prepay obligations with or without call or prepayment penalties. Investment Concentrations The Company's process for investing in credit-related investments begins with an independent approach to underwriting each issuer's fundamental credit quality. The Company evaluates independently those factors that it believes could influence an issuer's ability to make payments under the contractual terms of the Company's instruments. This includes a thorough analysis of a variety of items including the issuer's country of domicile (including political, legal, and financial considerations); the industry in which the issuer competes (with an analysis of industry structure, end-market dynamics, and regulation); company specific issues (such as management, assets, earnings, cash generation, and capital needs); and contractual provisions of the instrument (such as financial covenants and position in the capital structure). The Company further evaluates the investment considering broad business and portfolio management objectives, including asset/liability needs, portfolio diversification, and expected income. Investment exposures that individually exceeded 10% of shareholders' equity were as follows:
Realized Investment Gains and Losses Information regarding pretax realized gains and losses from investments is as follows:
The unrealized holding gains, net of losses, recorded as a component of realized investment gains and losses for the three-month period ended March 31, 2019, that relates to equity securities still held at the March 31, 2019, reporting date was $47 million. Unrealized Investment Gains and Losses Effect on Shareholders’ Equity The net effect on shareholders’ equity of unrealized gains and losses from fixed maturity securities was as follows:
Gross Unrealized Loss Aging The following tables show the fair values and gross unrealized losses of the Company's available-for-sale and held-to-maturity investments that were in an unrealized loss position, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position.
Analysis of Securities in Unrealized Loss Positions The unrealized losses on the Company's fixed maturity securities investments have been primarily related to general market changes in interest rates, foreign exchange rates, and/or the levels of credit spreads rather than specific concerns with the issuer's ability to pay interest and repay principal. For any significant declines in fair value of its fixed maturity securities, the Company performs a more focused review of the related issuers' credit profile. For corporate issuers, the Company evaluates their assets, business profile including industry dynamics and competitive positioning, financial statements and other available financial data. For non-corporate issuers, the Company analyzes all sources of credit support, including issuer-specific factors. The Company utilizes information available in the public domain and, for certain private placement issuers, from consultations with the issuers directly. The Company also considers ratings from Nationally Recognized Statistical Rating Organizations (NRSROs), as well as the specific characteristics of the security it owns including seniority in the issuer's capital structure, covenant protections, or other relevant features. From these reviews, the Company evaluates the issuers' continued ability to service the Company's investment through payment of interest and principal. Assuming no credit-related factors develop, unrealized gains and losses on fixed maturity securities are expected to diminish as investments near maturity. Based on its credit analysis, the Company believes that the issuers of its fixed maturity investments in the sectors shown in the table above have the ability to service their obligations to the Company. Commercial Mortgage and Other Loans The Company classifies its transitional real estate loans (TREs), commercial mortgage loans (CMLs) and middle market loans (MMLs) as held-for-investment and includes them in the commercial mortgage and other loans line on the consolidated balance sheets. The Company carries them on the balance sheet at amortized cost less an estimated allowance for loan losses. The following table reflects the composition of commercial mortgage and other loans by portfolio segment as of the periods presented.
Commercial mortgage and transitional real estate loans were secured by properties entirely within the United States. Middle market loans are issued only to companies domiciled within the United States. Transitional Real Estate Loans Transitional real estate loans are commercial mortgage loans that are typically relatively short-term floating rate instruments secured by a first lien on the property. These loans provide funding for properties undergoing a change in their physical characteristics and/or economic profile and do not typically require any principal repayment prior to the maturity date. This loan portfolio has guidelines that limit the average loan-to-value at origination to be 70% or lower with individual loan-to-value limits at origination of 80% or less. As of March 31, 2019, the Company had $733 million in outstanding commitments to fund transitional real estate loans. These commitments are contingent on the final underwriting and due diligence to be performed. Commercial Mortgage Loans Commercial mortgage loans are typically fixed rate loans on commercial real estate with partial repayment of principal over the life of the loan with the remaining outstanding principal being repaid upon maturity. This loan portfolio has guidelines that limit the average loan-to-value at origination to be 65% or lower with individual loan-to-value limits at origination of 70% or less. As of March 31, 2019, the Company had $28 million in outstanding commitments to fund commercial mortgage loans. These commitments are contingent on the final underwriting and due diligence to be performed. Middle Market Loans Middle market loans are typically first lien senior secured cash flow loans to small to mid-size companies for working capital, refinancing, acquisition, and recapitalization. These loans are generally considered to be below investment grade. The carrying value for middle market loans included an unfunded amount of $127 million and $56 million, as of March 31, 2019, and December 31, 2018, respectively, that is reflected in other liabilities on the consolidated balance sheets. As of March 31, 2019, the Company had commitments of approximately $677 million to fund potential future loan originations related to this investment program. These commitments are contingent upon the availability of middle market loans that meet the Company's underwriting criteria. Allowance for Loan Losses The Company's allowance for loan losses is established using both general and specific allowances. The general allowance is used for loans grouped by similar risk characteristics where a loan-specific or market-specific risk has not been identified, but for which the Company estimates probable incurred losses. The specific allowance is used on an individual loan basis when it is probable that a loss has been incurred. There was no specific loan loss reserve as of March 31, 2019, and December 31, 2018. As of March 31, 2019, and December 31, 2018, the Company's general allowance for loan losses was $29 million and $27 million, respectively. The following table presents the rollforward of the allowance for loan losses by portfolio segment during the three-month period ended March 31.
The key credit quality indicators used by the company in establishing the general and specific loan loss reserves, as well as in determining whether or not a loan should be impaired, include loan-to-value and debt service coverage ratios for CMLs and TREs and ratings for our middle market loan portfolio. Given that transitional real estate loans involve properties undergoing renovation or construction, loan-to-value provides the most insight on the credit risk of the property. The performance of the loans are monitored and reviewed periodically, but not less than quarterly. As of March 31, 2019, and December 31, 2018, the Company had no loans that were past due in regards to principal and/or interest payments. Additionally, the Company held no loans that were on nonaccrual status or considered impaired as of March 31, 2019, and December 31, 2018. The Company had no troubled debt restructurings during the three months ended March 31, 2019 and 2018. Other Investments The table below reflects the composition of the carrying value for other investments as of the periods presented.
(1) Includes securities lending collateral As of March 31, 2019, the Company had $915 million in outstanding commitments to fund alternative investments in limited partnerships. Variable Interest Entities (VIEs) As a condition of its involvement or investment in a VIE, the Company enters into certain protective rights and covenants that preclude changes in the structure of the VIE that would alter the creditworthiness of the Company's investment or its beneficial interest in the VIE. For those VIEs other than certain unit trust structures, the Company's involvement is passive in nature. The Company has not, nor has it been, required to purchase any securities issued in the future by these VIEs. The Company's ownership interest in VIEs is limited to holding the obligations issued by them. The Company has no direct or contingent obligations to fund the limited activities of these VIEs, nor does it have any direct or indirect financial guarantees related to the limited activities of these VIEs. The Company has not provided any assistance or any other type of financing support to any of the VIEs it invests in, nor does it have any intention to do so in the future. For those VIEs in which the Company holds debt obligations, the weighted-average lives of the Company's notes are very similar to the underlying collateral held by these VIEs where applicable. The Company's risk of loss related to its interests in any of its VIEs is limited to the carrying value of the related investments held in the VIE. VIEs - Consolidated The following table presents the cost or amortized cost, fair value and balance sheet caption in which the assets and liabilities of consolidated VIEs are reported. Investments in Consolidated Variable Interest Entities
(1) Consists entirely of alternative investments in limited partnerships (2) Consists entirely of derivatives The Company is substantively the only investor in the consolidated VIEs listed in the table above. As the sole investor in these VIEs, the Company has the power to direct the activities of a variable interest entity that most significantly impact the entity's economic performance and is therefore considered to be the primary beneficiary of the VIEs that it consolidates. The Company also participates in substantially all of the variability created by these VIEs. The activities of these VIEs are limited to holding invested assets and foreign currency swaps, as appropriate, and utilizing the cash flows from these securities to service its investment. Neither the Company nor any of its creditors are able to obtain the underlying collateral of the VIEs unless there is an event of default or other specified event. For those VIEs that contain a swap, the Company is not a direct counterparty to the swap contracts and has no control over them. The Company's loss exposure to these VIEs is limited to its original investment. The Company's consolidated VIEs do not rely on outside or ongoing sources of funding to support their activities beyond the underlying collateral and swap contracts, if applicable. With the exception of its investment in unit trust structures, the underlying collateral assets and funding of the Company's consolidated VIEs are generally static in nature. Investments in Unit Trust Structures The Company also utilizes unit trust structures in its Aflac Japan segment to invest in various asset classes. As the sole investor of these VIEs, the Company is required to consolidate these trusts under U.S. GAAP. VIEs - Not Consolidated The table below reflects the amortized cost, fair value and balance sheet caption in which the Company's investment in VIEs not consolidated are reported. Investments in Variable Interest Entities Not Consolidated
(1) Consists entirely of alternative investments in limited partnerships The Company holds alternative investments in limited partnerships that have been determined to be VIEs. These partnerships invest in private equity and structured investments. The Company’s maximum exposure to loss on these investments is limited to the amount of its investment. The Company is not the primary beneficiary of these VIEs and is therefore not required to consolidate them. The Company classifies these investments as Other investments in the consolidated balance sheets. Certain investments in VIEs that the Company is not required to consolidate are investments that are in the form of debt obligations from the VIEs that are irrevocably and unconditionally guaranteed by their corporate parents or sponsors. These VIEs are the primary financing vehicles used by their corporate sponsors to raise financing in the capital markets. The variable interests created by these VIEs are principally or solely a result of the debt instruments issued by them. The Company does not have the power to direct the activities that most significantly impact the entity's economic performance, nor does it have the obligation to absorb losses of the entity or the right to receive benefits from the entity. As such, the Company is not the primary beneficiary of these VIEs and is therefore not required to consolidate them. Securities Lending and Pledged Securities The Company lends fixed maturity and public equity securities to financial institutions in short-term security-lending transactions. These short-term security-lending arrangements increase investment income with minimal risk. The Company receives cash or other securities as collateral for such loans. The Company's security lending policy requires that the fair value of the securities received as collateral be 102% or more of the fair value of the loaned securities and that unrestricted cash received as collateral be 100% or more of the fair value of the loaned securities. The securities loaned continue to be carried as investment assets on the Company's balance sheet during the terms of the loans and are not reported as sales. For loans involving unrestricted cash or securities as collateral, the collateral is reported as an asset with a corresponding liability for the return of the collateral. For loans where the Company receives as collateral securities that the Company is not permitted to sell or repledge, the collateral is not reflected on the consolidated financial statements. Details of collateral by loaned security type and remaining maturity of the agreements were as follows:
(1) The related loaned security, under the Company's U.S. securities lending program, can be returned to the Company at the transferee's discretion; therefore, they are classified as Overnight and Continuous.
(1) The related loaned security, under the Company's U.S. securities lending program, can be returned to the Company at the transferee's discretion; therefore, they are classified as Overnight and Continuous The Company did not have any repurchase agreements or repurchase-to-maturity transactions outstanding as of March 31, 2019, and December 31, 2018, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DERIVATIVE INSTRUMENTS |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DERIVATIVE INSTRUMENTS | DERIVATIVE INSTRUMENTS The Company's freestanding derivative financial instruments have historically consisted of:
Some of the Company's derivatives are designated as cash flow hedges, fair value hedges or net investment hedges; however, other derivatives do not qualify for hedge accounting or the Company elects not to designate them as accounting hedges. Derivative Types Foreign currency forwards and options are executed for the Aflac Japan segment in order to hedge the currency risk on the carrying value of certain U.S. dollar-denominated investments. The average maturity of these forwards and options can change depending on factors such as market conditions and types of investments being held. In situations where the maturity of the forwards and options is shorter than the underlying investment being hedged, the Company may enter into new forwards and options near maturity of the existing derivative in order to continue hedging the underlying investment. In forward transactions, Aflac Japan agrees with another party to buy a fixed amount of yen and sell a corresponding amount of U.S. dollars at a specified future date. Aflac Japan also executes foreign currency option transactions in a collar strategy, where Aflac Japan agrees with another party to simultaneously purchase put options and sell call options. In the purchased put transactions, Aflac Japan obtains the option to buy a fixed amount of yen and sell a corresponding amount of U.S. dollars at a specified future date. In the sold call transaction, Aflac Japan agrees to sell a fixed amount of yen and buy a corresponding amount of U.S. dollars at a specified future date. The combination of purchasing the put option and selling the call option results in no net premium being paid (i.e. a costless or zero-cost collar). The foreign currency forwards and options are used in fair value hedging relationships to mitigate the foreign exchange risk associated with U.S. dollar-denominated investments supporting yen-denominated liabilities. Prior to April 1, 2018, foreign currency forwards and options (through a collar strategy, as discussed above) were used to hedge the currency risk associated with the net investment in Aflac Japan. In these forward transactions, Aflac agreed with another party to buy a fixed amount of U.S. dollars and sell a corresponding amount of yen at a specified price at a specified future date. In the option transactions, the Company used a combination of foreign currency options to protect expected future cash flows by simultaneously purchasing yen put options (options that protect against a weakening yen) and selling yen call options (options that limit participation in a strengthening yen). The combination of these two actions created a zero-cost collar. The Company enters into foreign currency swaps pursuant to which it exchanges an initial principal amount in one currency for an initial principal amount of another currency, with an agreement to re-exchange the principal amounts at a future date. There may also be periodic exchanges of payments at specified intervals based on the agreed upon rates and notional amounts. Foreign currency swaps are used primarily in the consolidated VIEs in the Company's Aflac Japan portfolio to convert foreign-denominated cash flows to yen, the functional currency of Aflac Japan, in order to minimize cash flow fluctuations. The Company also uses foreign currency swaps to economically convert certain of its U.S. dollar-denominated senior note and subordinated debenture principal and interest obligations into yen-denominated obligations. In order to reduce investment income volatility from its variable-rate investments, the Company enters into receive–fixed, pay–floating interest rate swaps. These derivatives are cleared and settled through a central clearinghouse. Swaptions are used to mitigate the adverse impact resulting from significant changes in the fair value of U.S. dollar-denominated available-for-sale securities due to fluctuation in interest rates. In a payer swaption, the Company pays a premium to obtain the right, but not the obligation, to enter into a swap contract where it will pay a fixed rate and receive a floating rate. Interest rate swaption collars are combinations of two swaption positions. In order to maximize the efficiency of the collars while minimizing cost, a collar strategy is used whereby the Company purchases a long payer swaption (the Company purchases an option that allows it to enter into a swap where the Company will pay the fixed rate and receive the floating rate of the swap) and sells a short receiver swaption (the Company sells an option that provides the counterparty with the right to enter into a swap where the Company will receive the fixed rate and pay the floating rate of the swap). The combination of purchasing the long payer swaption and selling the short receiver swaption results in no net premium being paid (i.e. a costless or zero-cost collar). Derivative Balance Sheet Classification The table below summarizes the balance sheet classification of the Company's derivative fair value amounts, as well as the gross asset and liability fair value amounts. The fair value amounts presented do not include income accruals. Derivative assets are included in “Other Assets,” while derivative liabilities are included in “Other Liabilities” within the Company’s Consolidated Balance Sheets. The notional amount of derivative contracts represents the basis upon which pay or receive amounts are calculated and are not reflective of exposure or credit risk.
Cash Flow Hedges For certain variable-rate U.S. dollar-denominated available-for-sale securities held by Aflac Japan via consolidated VIEs, foreign currency swaps are used to swap the USD variable rate interest and principal payments to fixed rate JPY interest and principal payments. The Company has designated foreign currency swaps as a hedge of the variability in cash flows of a forecasted transaction or of amounts to be received or paid related to a recognized asset (“cash flow” hedge). The remaining maximum length of time for which these cash flows are hedged is eight years. The derivatives in the Company's consolidated VIEs that are not designated as accounting hedges are discussed in the "non-qualifying strategies" section of this note. Fair Value Hedges The Company designates and accounts for certain foreign currency forwards, options, and interest rate swaptions as fair value hedges when they meet the requirements for hedge accounting. The Company recognizes gains and losses on these derivatives as well as the offsetting gain or loss on the related hedged items in current earnings. Foreign currency forwards and options hedge the foreign currency exposure of certain U.S. dollar-denominated available-for-sale fixed-maturity investments held in Aflac Japan. The change in the fair value of the foreign currency forwards related to the changes in the difference between the spot rate and the forward price is excluded from the assessment of hedge effectiveness. The change in fair value of the foreign currency option related to the time value of the option is recognized in current earnings and is excluded from the assessment of hedge effectiveness. Interest rate swaptions hedge the interest rate exposure of certain U.S. dollar-denominated available-for-sale securities held in Aflac Japan. For these hedging relationships, the Company excludes time value from the assessment of hedge effectiveness and recognizes changes in the intrinsic value of the swaptions in current earnings within net investment income. The change in the time value of the swaptions is recognized in other comprehensive income (loss) and amortized into earnings (net investment income) over its legal term. The following table presents the gains and losses on derivatives and the related hedged items in fair value hedges. Fair Value Hedging Relationships
(1) Gains (losses) excluded from effectiveness testing includes the forward point on foreign currency forwards and time value change on foreign currency options which are reported in the consolidated statement of earnings as realized investment gains (losses). It also includes the change in the fair value of the interest rate swaptions related to the time value of the swaptions which is recognized as a component of other comprehensive income (loss). (2) Gains and losses on foreign currency forwards and options and related hedged items are reported in the consolidated statement of earnings as realized investment gains (losses). For interest rate swaptions and related hedged items, gains and losses included in the hedge assessment are reported within net investment income. For the three-month period ended March 31, 2019, those gains and losses on interest rate swaptions and related hedged items were immaterial. The following table shows the carrying amounts of assets designated and qualifying as hedged items in fair value hedges of interest rate risk and the related cumulative hedge adjustment included in the carrying amount.
(1) The balance includes hedging adjustment on discontinued hedging relationships of $276 in 2019 and $294 in 2018. The total notional amount of the Company's interest rate swaptions was $1,500 in 2019 and $500 in 2018. The hedging adjustment related to these derivatives was immaterial. Net Investment Hedge The Company's investment in Aflac Japan is affected by changes in the yen/dollar exchange rate. To mitigate this exposure, the Parent Company's yen-denominated liabilities (see Note 8) have been designated as non-derivative hedges and, prior to April 1, 2018, foreign currency forwards and options have been designated as derivative hedges of the foreign currency exposure of the Company's net investment in Aflac Japan. The Company's net investment hedge was effective during the three-month periods ended March 31, 2019 and 2018, respectively. Non-qualifying Strategies For the Company's derivative instruments in consolidated VIEs that do not qualify for hedge accounting treatment, all changes in their fair value are reported in current period earnings within realized investment gains (losses). The amount of gain or loss recognized in earnings for the Company's VIEs is attributable to the derivatives in those investment structures. While the change in value of the swaps is recorded through current period earnings, the change in value of the available-for-sale fixed maturity securities associated with these swaps is recorded through other comprehensive income. As of March 31, 2019, the Parent Company had cross-currency interest rate swap agreements related to its $350 million senior notes due February 2022, $700 million senior notes due June 2023, $750 million senior notes due November 2024 and $450 million senior notes due March 2025. Changes in the values of these swaps are recorded through current period earnings. For additional information regarding these swaps, see Note 9 of the Notes to the Consolidated Financial Statements in the 2018 Annual Report. The Company uses foreign exchange forwards and options to economically mitigate the currency risk of some of its U.S. dollar-denominated loan receivables held within the Aflac Japan segment. These arrangements are not designated as accounting hedges, as the foreign currency remeasurement of the loan receivables impacts current period earnings, and generally offsets gains and losses from foreign exchange forwards within realized investment gains (losses). The Company also has certain foreign exchange forwards on U.S. dollar-denominated AFS securities where hedge accounting is not being applied. In order to economically mitigate currency risk of future yen dividends from Aflac Japan while lowering consolidated hedge costs associated with Aflac Japan's U.S. dollar investment hedging, the Parent Company entered into offsetting hedge positions using foreign exchange forwards. This activity is reported in the Corporate and other segment. The Company uses interest rate swaps to economically convert the variable rate investment income to a fixed rate on certain variable-rate investments. Impact of Derivatives and Hedging Instruments The following table summarizes the impact to realized investment gains (losses) and other comprehensive income (loss) from all derivatives and hedging instruments.
(1) Net investment income (loss) includes net interest on swaps. (2) Cash flow hedge items and the change in the fair value of interest rate swaptions related to the time value of the swaptions in fair value hedges are recorded as unrealized gains (losses) on derivatives and net investment hedge items are recorded in the unrealized foreign currency translation gains (losses) line in the consolidated statement of comprehensive income (loss). (3) Impact of cash flow hedges reported as realized investment gains (losses) includes an immaterial amount of gains or losses reclassified from accumulated other comprehensive income (loss) into earnings. It also includes an immaterial amount excluded from effectiveness testing during the three-month periods ended March 31, 2019 and 2018, respectively. (4)Impact shown net of effect of hedged items (see Fair Value Hedges section of this Note 4 for further detail) The impact on earnings from derivatives in cash flow hedge relationships includes a loss of an immaterial amount during the three-month periods ended March 31, 2019 and 2018, respectively, resulting from reclassifications from accumulated other comprehensive income (loss) to net investment income. As of March 31, 2019, deferred gains and losses on derivative instruments recorded in accumulated other comprehensive income that are expected to be reclassified to earnings during the next twelve months were immaterial. Credit Risk Assumed through Derivatives For the foreign currency and credit default swaps associated with the Company's VIE investments for which it is the primary beneficiary, the Company bears the risk of loss due to counterparty default even though it is not a direct counterparty to those contracts. The Company is a direct counterparty to the foreign currency swaps that it has entered into in connection with certain of its senior notes and subordinated debentures; foreign currency forwards; and foreign currency options, and therefore the Company is exposed to credit risk in the event of nonperformance by the counterparties in those contracts. The risk of counterparty default for the Company's foreign currency swaps, certain foreign currency forwards, and foreign currency options is mitigated by collateral posting requirements that counterparties to those transactions must meet. As of March 31, 2019, there were 16 counterparties to the Company's derivative agreements, with four comprising 65% of the aggregate notional amount. As of March 31, 2019, all counterparties were investment grade. The Company engages in over-the-counter (OTC) bilateral derivative transactions directly with unaffiliated third parties under International Swaps and Derivatives Association, Inc. (ISDA) agreements and other documentation. Most of the ISDA agreements also include Credit Support Annexes (CSAs) provisions, which generally provide for two-way collateral postings at the first dollar of exposure. The Company mitigates the risk that counterparties to transactions might be unable to fulfill their contractual obligations by monitoring counterparty credit exposure and collateral value while generally requiring that collateral be posted at the outset of the transaction. In addition, a significant portion of the derivative transactions have provisions that give the counterparty the right to terminate the transaction upon a downgrade of Aflac’s financial strength rating. The actual amount of payments that the Company could be required to make depends on market conditions, the fair value of outstanding affected transactions, and other factors prevailing at and after the time of the downgrade. The Company also engages in OTC cleared derivative transactions through regulated central clearing counterparties. These positions are marked to market and margined on a daily basis (both initial margin and variation margin), and the Company has minimal exposure to credit-related losses in the event of nonperformance by counterparties to these derivatives. Collateral posted by the Company to third parties for derivative transactions can generally be repledged or resold by the counterparties. The aggregate fair value of all derivative instruments with credit-risk-related contingent features that were in a net liability position by counterparty was approximately $133 million and $139 million as of March 31, 2019, and December 31, 2018, respectively. If the credit-risk-related contingent features underlying these agreements had been triggered on March 31, 2019, the Company estimates that it would be required to post a maximum of $23 million of additional collateral to these derivative counterparties. The Company is generally allowed to sell or repledge collateral obtained from its derivative counterparties, although it does not typically exercise such rights. (See the Offsetting tables below for collateral posted or received as of the reported balance sheet dates.) Offsetting of Financial Instruments and Derivatives Most of the Company's derivative instruments are subject to enforceable master netting arrangements that provide for the net settlement of all derivative contracts between the Parent Company or its subsidiaries and the respective counterparty in the event of default or upon the occurrence of certain termination events. Collateral support agreements with the master netting arrangements generally provide that the Company will receive or pledge financial collateral at the first dollar of exposure. The Company has securities lending agreements with unaffiliated financial institutions that post collateral to the Company in return for the use of its fixed maturity and public equity securities (see Note 3). When the Company has entered into securities lending agreements with the same counterparty, the agreements generally provide for net settlement in the event of default by the counterparty. This right of set-off allows the Company to keep and apply collateral received if the counterparty failed to return the securities borrowed from the Company as contractually agreed. The tables below summarize the Company's derivatives and securities lending transactions, and as reflected in the tables, in accordance with U.S. GAAP, the Company's policy is to not offset these financial instruments in the Consolidated Balance Sheets. Offsetting of Financial Assets and Derivative Asset
Offsetting of Financial Liabilities and Derivative Liabilities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| FAIR VALUE MEASUREMENTS | FAIR VALUE MEASUREMENTS Fair Value Hierarchy U.S. GAAP specifies a hierarchy of valuation techniques based on whether the inputs to those valuation techniques are observable or unobservable. These two types of inputs create three valuation hierarchy levels. Level 1 valuations reflect quoted market prices for identical assets or liabilities in active markets. Level 2 valuations reflect quoted market prices for similar assets or liabilities in an active market, quoted market prices for identical or similar assets or liabilities in non-active markets or model-derived valuations in which all significant valuation inputs are observable in active markets. Level 3 valuations reflect valuations in which one or more of the significant inputs are not observable in an active market. The following tables present the fair value hierarchy levels of the Company's assets and liabilities that are measured and carried at fair value on a recurring basis.
The following tables present the carrying amount and fair value categorized by fair value hierarchy level for the Company's financial instruments that are not carried at fair value.
(1) Excludes policy loans of $236 and equity method investments of $434, at carrying value
(1) Excludes policy loans of $232 and equity method investments of $377, at carrying value Fair Value of Financial Instruments Fixed maturity and equity securities The Company determines the fair values of fixed maturity securities and public and privately-issued equity securities using the following approaches or techniques: price quotes and valuations from third party pricing vendors (including quoted market prices readily available from public exchange markets) and non-binding price quotes the Company obtains from outside brokers. A third party pricing vendor has developed valuation models to determine fair values of privately issued securities to reflect the impact of the persistent economic environment and the changing regulatory framework. These models are discounted cash flow (DCF) valuation models, but also use information from related markets, specifically the CDS market to estimate expected cash flows. These models take into consideration any unique characteristics of the securities and make various adjustments to arrive at an appropriate issuer-specific loss adjusted credit curve. This credit curve is then used with the relevant recovery rates to estimate expected cash flows and modeling of additional features, including illiquidity adjustments, if necessary, to price the security by discounting those loss adjusted cash flows. In cases where a credit curve cannot be developed from the specific security features, the valuation methodology takes into consideration other market observable inputs, including: 1) the most appropriate comparable security(ies) of the issuer; 2) issuer-specific CDS spreads; 3) bonds or CDS spreads of comparable issuers with similar characteristics such as rating, geography, or sector; or 4) bond indices that are comparative in rating, industry, maturity and region. The pricing data and market quotes the Company obtains from outside sources, including third party pricing services, are reviewed internally for reasonableness. If a fair value appears unreasonable, the Company will re-examine the inputs and assess the reasonableness of the pricing data with the vendor. Additionally, the Company may compare the inputs to relevant market indices and other performance measurements. Based on management's analysis, the valuation is confirmed or may be revised if there is evidence of a more appropriate estimate of fair value based on available market data. The Company has performed verification of the inputs and calculations in any valuation models to confirm that the valuations represent reasonable estimates of fair value. The fixed maturity securities classified as Level 3 consist of securities with limited or no observable valuation inputs. For Level 3 securities, the Company estimates the fair value of these securities by obtaining non-binding broker quotes from a limited number of brokers. These brokers base their quotes on a combination of their knowledge of the current pricing environment and market conditions. The Company considers these inputs to be unobservable. The Company also considers a variety of significant valuation inputs in the valuation process, including forward exchange rates, yen swap rates, dollar swap rates, interest rate volatilities, credit spread data on specific issuers, assumed default and default recovery rates, and certain probability assumptions. In obtaining these valuation inputs, the Company has determined that certain pricing assumptions and data used by its pricing sources are difficult to validate or corroborate by the market and/or appear to be internally developed rather than observed in or corroborated by the market. The use of these unobservable valuation inputs causes more subjectivity in the valuation process for these securities. For the periods presented, the Company has not adjusted the quotes or prices it obtains from the pricing services and brokers it uses. The following tables present the pricing sources for the fair values of the Company's fixed maturity and equity securities.
The following is a discussion of the determination of fair value of the Company's remaining financial instruments. Derivatives The Company uses derivative instruments to manage the risk associated with certain assets. However, the derivative instrument may not be classified in the same fair value hierarchy level as the associated asset. The Company uses pricing models to determine the estimated fair value of derivatives. Inputs used to value derivatives include, but are not limited to, interest rates, credit spreads, foreign currency forward and spot rates, and interest volatility. The significant inputs to pricing derivatives are generally observable in the market or can be derived by observable market data. When these inputs are observable, the derivatives are classified as Level 2. The fair values of the foreign currency forwards and options associated with certain investments; the foreign currency forwards and options used to hedge foreign exchange risk from the Company's net investment in Aflac Japan and economically hedge certain portions of forecasted cash flows denominated in yen; and the foreign currency swaps associated with certain senior notes are based on the amounts the Company would expect to receive or pay. The determination of the fair value of these derivatives is based on observable market inputs, therefore they are classified as Level 2. To determine the fair value of its interest rate derivatives, the Company uses inputs that are generally observable in the market or can be derived from observable market data. Interest rate swaps are cleared trades. In a cleared swap contract, the clearinghouse provides benefits to the counterparties similar to contracts listed for investment traded on an exchange since it maintains a daily margin to mitigate counterparties' credit risk. These derivatives are priced using observable inputs, accordingly, they are classified as Level 2. For its interest rate swaptions, the Company estimates their fair values using observable market data, including interest rate curves and volatilities. Their fair values are also classified as Level 2. For derivatives associated with VIEs where the Company is the primary beneficiary, the Company is not the direct counterparty to the swap contracts. As a result, the fair value measurements incorporate the credit risk of the collateral associated with the VIE. The Company receives valuations from a third party pricing vendor for these derivatives. Based on an analysis of these derivatives and a review of the methodology employed by the pricing vendor, the Company determined that due to the long duration of these swaps and the need to extrapolate from short-term observable data to derive and measure long-term inputs, certain inputs, assumptions and judgments are required to value future cash flows that cannot be corroborated by current inputs or current observable market data. As a result, the derivatives associated with the Company's consolidated VIEs are classified as Level 3 of the fair value hierarchy. Commercial mortgage and other loans Commercial mortgage and other loans include transitional real estate loans, commercial mortgage loans and middle market loans. The Company's loan receivables do not have readily determinable market prices and generally lack market liquidity. Fair values for loan receivables are determined based on the present value of expected future cash flows discounted at the applicable U.S. Treasury or London Interbank Offered Rate (LIBOR) yield plus an appropriate spread that considers other risk factors, such as credit and liquidity risk. These spreads are provided by the applicable asset managers based on their knowledge of the current loan pricing environment and market conditions. The spreads are a significant component of the pricing inputs and are generally considered unobservable. Therefore, these investments have been assigned a Level 3 within the fair value hierarchy. Other investments Other investments includes short-term investments that are measured at fair value where amortized cost approximates fair value. Other policyholders' funds The largest component of the other policyholders' funds liability is the Company's annuity line of business in Aflac Japan. The Company's annuities have fixed benefits and premiums. For this product, the Company estimates the fair value to be equal to the cash surrender value. This is analogous to the value paid to policyholders on the valuation date if they were to surrender their policy. The Company periodically checks the cash value against discounted cash flow projections for reasonableness. The Company considers its inputs for this valuation to be unobservable and have accordingly classified this valuation as Level 3. Notes payable During the three-month periods ended March 31, 2019 and 2018, respectively, there were no transfers between Level 1 and 2 for assets and liabilities that are measured and carried at fair value on a recurring basis. The following tables present the changes in fair value of the Company's investments and derivatives carried at fair value classified as Level 3.
(1) Derivative assets and liabilities are presented net (2) Transfer due to sector classification change (3) Transfer due to availability of observable market inputs
Level 3 Significant Unobservable Input Sensitivity The following tables summarize the significant unobservable inputs used in the valuation of the Company's Level 3 investments and derivatives carried at fair value. Included in the tables are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments.
(a) N/A represents securities where the Company receives unadjusted broker quotes and for which there is no transparency into the providers' valuation techniques or unobservable inputs. (b) Inputs derived from U.S. long-term rates to accommodate long maturity nature of the Company's swaps (c) Inputs derived from Japan long-term rates to accommodate long maturity nature of the Company's swaps
(a) N/A represents securities where the Company receives unadjusted broker quotes and for which there is no transparency into the providers' valuation techniques or unobservable inputs. (b) Inputs derived from U.S. long-term rates to accommodate long maturity nature of the Company's swaps (c) Inputs derived from Japan long-term rates to accommodate long maturity nature of the Company's swapsThe following is a discussion of the significant unobservable inputs or valuation techniques used in determining the fair value of securities and derivatives classified as Level 3.Net Asset Value The Company holds certain unlisted equity securities whose fair value is derived based on the financial statements published by the investee. These securities do not trade on an active market and the valuations derived are dependent on the availability of timely financial reporting of the investee. Net asset value is an unobservable input in the determination of fair value of equity securities. Offered Quotes In circumstances where the Company's valuation model price is overridden because it implies a value that is not consistent with current market conditions, the Company will solicit bids from a limited number of brokers. The Company also receives unadjusted prices from brokers for its mortgage and asset-backed securities. These quotes are non-binding but are reflective of valuation best estimates at that particular point in time. Offered quotes are an unobservable input in the determination of fair value of mortgage- and asset-backed securities, certain banks/financial institutions, certain other corporate, and equity securities investments. Interest Rates and CDS Spreads The significant drivers of the valuation of the interest and foreign exchange swaps are interest rates and CDS spreads. Some of the Company's swaps have long maturities that increase the sensitivity of the swaps to interest rate fluctuations. For the Company's foreign exchange or cross currency swaps that are in a net asset position, an increase in yen interest rates (all other factors held constant) will decrease the present value of the yen final settlement receivable (receive leg), thus decreasing the value of the swap as long as the derivative remains in a net asset position. Foreign exchange swaps also have a lump-sum final settlement of foreign exchange principal amounts at the termination of the swap. Assuming all other factors are held constant, an increase in yen interest rates will decrease the receive leg and decrease the net value of the swap. Likewise, holding all other factors constant, an increase in U.S. dollar interest rates will increase the swap's net value due to the decrease in the present value of the dollar final settlement payable (pay leg). The extinguisher feature in most of the Company's VIE swaps results in a cessation of cash flows and no further payments between the parties to the swap in the event of a default on the referenced or underlying collateral. To price this feature, the Company applies the survival probability of the referenced entity to the projected cash flows. The survival probability uses the CDS spreads and recovery rates to adjust the present value of the cash flows. For extinguisher swaps with positive values, an increase in CDS spreads decreases the likelihood of receiving the final exchange payments and reduces the value of the swap. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
POLICY LIABILITIES |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance Loss Reserves [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| POLICY LIABILITIES | POLICY LIABILITIES Changes in the liability for unpaid policy claims were as follows:
The incurred claims development related to prior years reflects favorable claims experience compared to previous estimates. The favorable claims development of $167 million for the three-month period ended March 31, 2019 comprises approximately $91 million from Japan, which represents approximately 54% of the total. The impact of foreign currency exchange for the period December 31, 2018 to March 31, 2019 was immaterial. The Company has experienced continued favorable claim trends in 2019 for its core health products in Japan. The Company's experience in Japan related to the average length of stay in the hospital for cancer treatment has shown continued decline in the current period. In addition, cancer treatment patterns in Japan are continuing to be influenced by significant advances in early-detection techniques and by the increased use of pathological diagnosis rather than clinical exams. Additionally, follow-up radiation and chemotherapy treatments are occurring more often on an outpatient basis. Such changes in treatment not only increase the quality of life and initial outcomes for the patients, but also decrease the average length of each hospital stay, resulting in favorable claims development. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REINSURANCE |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| REINSURANCE | REINSURANCE The Company periodically enters into fixed quota-share coinsurance agreements with other companies in the normal course of business. For each of its reinsurance agreements, the Company determines whether the agreement provides indemnification against loss or liability relating to insurance risk in accordance with applicable accounting standards. Reinsurance premiums and benefits paid or provided are accounted for on bases consistent with those used in accounting for the original policies issued and the terms of the reinsurance contracts. Premiums and benefits are reported net of insurance ceded. The Company has recorded a deferred profit liability related to reinsurance transactions. The remaining deferred profit liability of $1.0 billion, as of March 31, 2019, is included in future policy benefits in the consolidated balance sheet and is being amortized into income over the expected lives of the policies. The Company has also recorded a reinsurance recoverable for reinsurance transactions, which is included in other assets in the consolidated balance sheet and had a remaining balance of $944 million and $941 million as of March 31, 2019, and December 31, 2018, respectively. The increase in the reinsurance recoverable balance was driven by the growth in reserves related to the business that has been reinsured as the policies age. The ceded reserves increased approximately .3% from December 31, 2018, to March 31, 2019. The following table reconciles direct premium income and direct benefits and claims to net amounts after the effect of reinsurance.
These reinsurance transactions are indemnity reinsurance that do not relieve the Company from its obligations to policyholders. In the event that the reinsurer is unable to meet their obligations, the Company remains liable for the reinsured claims. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NOTES PAYABLE AND LEASE OBLIGATIONS |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| NOTES PAYABLE AND LEASE OBLIGATIONS | NOTES PAYABLE AND LEASE OBLIGATIONS A summary of notes payable and lease obligations follows:
(1) See Note 1 of the Notes to the Consolidated Financial Statements for the adoption of accounting guidance on January 1, 2019 related to leases. Amounts in the table above are reported net of debt issuance costs and issuance premiums or discounts, if applicable, that are being amortized over the life of the notes. The following table presents the contractual maturities and present value of lease liabilities.
The following table presents the weighted average remaining lease term and weighted average discount rate for lease liabilities.
(1) Intercompany credit agreement (2) Renewed in April 2019 with an expiration date of April 2, 2020 The Company was in compliance with all of the covenants of its notes payable and lines of credit at March 31, 2019. No events of default or defaults occurred during the three-month period ended March 31, 2019. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHAREHOLDERS' EQUITY |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SHAREHOLDERS' EQUITY | SHAREHOLDERS’ EQUITY The following table is a reconciliation of the number of shares of the Company's common stock for the three-month periods ended March 31.
Outstanding share-based awards are excluded from the calculation of weighted-average shares used in the computation of basic earnings per share (EPS). The following table presents the approximate number of share-based awards to purchase shares, on a weighted-average basis, that were considered to be anti-dilutive and were excluded from the calculation of diluted earnings per share for the following periods.
Share Repurchase Program During the first three months of 2019, the Company repurchased 10.2 million shares of its common stock in the open market for $490 million as part of its share repurchase program. During the first three months of 2018, the Company repurchased 6.6 million shares of its common stock in the open market for $296 million as part of its share repurchase program. As of March 31, 2019, a remaining balance of 58.8 million shares of the Company's common stock was available for purchase under share repurchase authorizations by its board of directors. Reclassifications from Accumulated Other Comprehensive Income The tables below are reconciliations of accumulated other comprehensive income by component for the following periods. Changes in Accumulated Other Comprehensive Income
All amounts in the table above are net of tax.
(1) Includes amounts reclassified due to changes in accounting principles of $(148) related to financial instruments and $374 related to tax effects from tax reform All amounts in the table above are net of tax. The tables below summarize the amounts reclassified from each component of accumulated other comprehensive income into net earnings for the following periods. Reclassifications Out of Accumulated Other Comprehensive Income
(1) Based on 25% blended tax rate (2) These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 11 for additional details).
(1) Based on 27% blended tax rate (2) These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 11 for additional details).
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHARE-BASED COMPENSATION |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| SHARE-BASED COMPENSATION | SHARE-BASED COMPENSATION As of March 31, 2019, the Company has outstanding share-based awards under the Aflac Incorporated Long-Term Incentive Plan (the Plan). Share-based awards are designed to reward employees for their long-term contributions to the Company and provide incentives for them to remain with the Company. The number and frequency of share-based awards are based on competitive practices, operating results of the Company, government regulations, and other factors. The Plan, as amended on February 14, 2017, allows for a maximum number of shares issuable over its term of 75 million shares including 38 million shares that may be awarded in respect of awards other than options or stock appreciation rights. If any awards granted under the Plan are forfeited or are terminated before being exercised or settled for any reason other than tax forfeiture, then the shares underlying the awards will again be available under the Plan. The Plan allows awards to Company employees for incentive stock options (ISOs), non-qualifying stock options (NQSOs), restricted stock, restricted stock units, and stock appreciation rights. Non-employee directors are eligible for grants of NQSOs, restricted stock, and stock appreciation rights. As of March 31, 2019, approximately 39.4 million shares were available for future grants under this plan. The ISOs and NQSOs have a term of 10 years, and the share-based awards generally vest upon time-based conditions or time and performance-based conditions. Time-based vesting generally occurs after three years. Performance-based vesting conditions generally include the attainment of goals related to Company financial performance. As of March 31, 2019, the only performance-based awards issued and outstanding were restricted stock awards. Stock options and stock appreciation rights granted under the amended Plan have an exercise price of at least the fair market value of the underlying stock on the grant date and have an expiration date no later than 10 years from the grant date. Time-based restricted stock awards, restricted stock units and stock options granted after January 1, 2017 generally vest on a ratable basis over three years, and awards granted prior to the amendment vest on a three years cliff basis. The Compensation Committee of the Board of Directors has the discretion to determine vesting schedules. Share-based awards granted to U.S.-based grantees are settled with authorized but unissued Company stock, while those issued to Japan-based grantees are settled with treasury shares. The following table provides information on stock options outstanding and exercisable at March 31, 2019.
The Company received cash from the exercise of stock options in the amount of $17 million during the first three months of 2019, compared with $23 million in the first three months of 2018. The tax benefit realized as a result of stock option exercises and restricted stock releases was $22 million in the first three months of 2019, compared with $12 million in the first three months of 2018. As of March 31, 2019, total compensation cost not yet recognized in the Company's financial statements related to restricted stock awards was $70 million, of which $33 million (824 thousand shares) was related to restricted stock awards with a performance-based vesting condition. The Company expects to recognize these amounts over a weighted-average period of approximately 1.4 years. There are no other contractual terms covering restricted stock awards once vested. The following table summarizes restricted stock activity during the three-month period ended March 31.
In February 2019, the Company granted 399 thousand performance-based stock awards, which are contingent on the achievement of the Company's financial performance metrics and its market-based conditions. On the date of grant, the Company estimated the fair value of restricted stock awards with market-based conditions using a Monte Carlo simulation model. The model discounts the value of the stock at the assumed vesting date based on the risk-free interest rate. Based on estimates of actual performance versus the vesting thresholds, the calculated fair value percentage pay-out estimate will be updated each quarter. The Company uses third-party analyses to assist in developing the assumptions used in, as well as calibrating, a Monte Carlo simulation model. The Company is responsible for determining the assumptions used in estimating the fair value of its share-based payment awards. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BENEFIT PLANS |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BENEFIT PLANS | BENEFIT PLANS The Company has funded defined benefit plans in Japan and the United States, however the U.S. plan was frozen to new participants effective October 1, 2013. The Company also maintains non-qualified, unfunded supplemental retirement plans that provide defined pension benefits in excess of limits imposed by federal tax law for certain Japanese, U.S. and former employees, however the U.S. plan was frozen to new participants effective January 1, 2015. U.S. employees who are not participants in the defined benefit plan receive a nonelective 401(k) employer contribution. The Company provides certain health care benefits for eligible U.S. retired employees, their beneficiaries and covered dependents (other postretirement benefits). The health care plan is contributory and unfunded. Effective January 1, 2014, employees eligible for benefits included the following: (1) active employees whose age plus service, in years, equaled or exceeded 80 (rule of 80); (2) active employees who were age 55 or older and have met the 15 years of service requirement; (3) active employees who would meet the rule of 80 in the next 5 years; (4) active employees who were age 55 or older and who would meet the 15 years of service requirement within the next 5 years; and (5) current retirees. For certain employees and former employees, additional coverage is provided for all medical expenses for life. Pension and other postretirement benefit expenses are included in acquisition and operating expenses in the consolidated statement of earnings, which includes other components of net periodic pension cost and postretirement costs (other than service costs) of $5 million for both the periods ended March 31, 2019 and 2018. Total net periodic cost includes the following components:
During the three months ended March 31, 2019, Aflac Japan contributed approximately $9 million (using the weighted-average yen/dollar exchange rate for the three-month period ending March 31, 2019) to the Japanese funded defined benefit plan, and Aflac U.S. contributed $10 million to the U.S. funded defined benefit plan. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
COMMITMENTS AND CONTINGENT LIABILITIES |
3 Months Ended |
|---|---|
Mar. 31, 2019 | |
| Commitments and Contingencies Disclosure [Abstract] | |
| COMMITMENTS AND CONTINGENT LIABILITIES | COMMITMENTS AND CONTINGENT LIABILITIES Effective for 2019, the Company entered into an outsourcing agreement with an information technology and data services company to provide application maintenance and development services for its Japanese operation. As of March 31, 2019, the agreement has a remaining term of five years and an aggregate remaining cost of 9.7 billion yen ($87 million using the March 31, 2019, exchange rate). The Company is a defendant in various lawsuits considered to be in the normal course of business. Members of the Company's senior legal and financial management teams review litigation on a quarterly and annual basis. The final results of any litigation cannot be predicted with certainty. Although some of this litigation is pending in states where large punitive damages, bearing little relation to the actual damages sustained by plaintiffs, have been awarded in recent years, the Company believes the outcome of pending litigation will not have a material adverse effect on its financial position, results of operations, or cash flows. See Note 3 of the Notes to the Consolidated Financial Statements for details on certain investment commitments. Guaranty Fund Assessments The United States insurance industry has a policyholder protection system that is monitored and regulated by state insurance departments. These life and health insurance guaranty associations are state entities (in all 50 states as well as Puerto Rico and the District of Columbia) created to protect policyholders of an insolvent insurance company. All insurance companies (with limited exceptions) licensed to sell life or health insurance in a state must be members of that state’s guaranty association. Under state guaranty association laws, certain insurance companies can be assessed (up to prescribed limits) for certain obligations to the policyholders and claimants of impaired or insolvent insurance companies that write the same line or similar lines of business. In 2009, the Pennsylvania Insurance Commissioner placed long-term care insurer Penn Treaty Network America Insurance Company and its subsidiary American Network Insurance Company (collectively referred to as Penn Treaty), neither of which is affiliated with Aflac, in rehabilitation and petitioned a state court for approval to liquidate Penn Treaty. A final order of liquidation was granted by a recognized judicial authority on March 1, 2017, and as a result, Penn Treaty is in the process of liquidation. The Company estimated and recognized the impact of its share of guaranty fund assessments resulting from the liquidation using a discounted rate of 4.25%. The Company recognized a discounted liability for the assessments of $62 million (undiscounted $94 million), offset by discounted premium tax credits of $48 million (undiscounted $74 million), for a net $14 million impact to net income in the quarter ended March 31, 2017. The Company paid a majority of these assessments by March 31, 2019. The Company used the cost estimate provided as of the liquidation date by the National Organization of Life and Health Guaranty Associations (NOLHGA) to calculate its estimated assessments and tax credits. |
SUBSEQUENT EVENTS |
3 Months Ended |
|---|---|
Mar. 31, 2019 | |
| Subsequent Events [Abstract] | |
| SUBSEQUENT EVENTS | SUBSEQUENT EVENTSOn April 12, 2019, the Company announced that ALIJ priced 30.0 billion yen (par value) of perpetual subordinated bonds. These bonds will bear interest at a fixed rate of .963% per annum and then at six-month Euro Yen LIBOR plus an applicable spread on and after the day immediately following April 18, 2024. The bonds will be callable on each interest payment date on and after April 18, 2024. ALIJ anticipates using the net proceeds of the offering for general corporate purposes. |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||
| Organization, Consolidation and Presentation of Financial Statements [Abstract] | |||||||||||||||||||||||||||||||||||||
| Description of Business and Basis of Presentation | Description of Business Aflac Incorporated (the Parent Company) and its subsidiaries (collectively, the Company) primarily sell supplemental health and life insurance in the United States and Japan. The Company's insurance business is marketed and administered through American Family Life Assurance Company of Columbus (Aflac) in the United States and, effective April 1, 2018, through Aflac Life Insurance Japan Ltd. (ALIJ) in Japan. Prior to April 1, 2018, the Company's insurance business was marketed in Japan as a branch of Aflac. The Company’s operations consist of two reportable business segments: Aflac U.S., which includes Aflac, and Aflac Japan, which includes ALIJ. American Family Life Assurance Company of New York (Aflac New York) is a wholly owned subsidiary of Aflac. Most of Aflac's policies are individually underwritten and marketed through independent agents. Additionally, Aflac U.S. markets and administers group products through Continental American Insurance Company (CAIC), branded as Aflac Group Insurance. The Company's insurance operations in the United States and Japan service the two markets for the Company's insurance business. Aflac Japan's revenues, including realized gains and losses on its investment portfolio, accounted for 68% and 71% of the Company's total revenues in the three-month periods ended March 31, 2019 and 2018, respectively. The percentage of the Company's total assets attributable to Aflac Japan was 84% at March 31, 2019 and December 31, 2018, respectively. Basis of Presentation The Company prepares its financial statements in accordance with U.S. generally accepted accounting principles (U.S. GAAP). These principles are established primarily by the Financial Accounting Standards Board (FASB). In these Notes to the Consolidated Financial Statements, references to U.S. GAAP issued by the FASB are derived from the FASB Accounting Standards CodificationTM (ASC). The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates based on currently available information when recording transactions resulting from business operations. The most significant items on the Company's balance sheet that involve a greater degree of accounting estimates and actuarial determinations subject to changes in the future are the valuation of investments and derivatives, deferred policy acquisition costs (DAC), liabilities for future policy benefits and unpaid policy claims, and income taxes. These accounting estimates and actuarial determinations are sensitive to market conditions, investment yields, mortality, morbidity, commission and other acquisition expenses, and terminations by policyholders. As additional information becomes available, or actual amounts are determinable, the recorded estimates will be revised and reflected in operating results. Although some variability is inherent in these estimates, the Company believes the amounts provided are adequate. The unaudited consolidated financial statements include the accounts of the Parent Company, its subsidiaries and those entities required to be consolidated under applicable accounting standards. All material intercompany accounts and transactions have been eliminated. In the opinion of management, the accompanying unaudited consolidated financial statements of the Company contain all adjustments, consisting of normal recurring accruals, which are necessary to fairly present the consolidated balance sheets as of March 31, 2019, and December 31, 2018, the consolidated statements of earnings and comprehensive income (loss), shareholders' equity and cash flows for the three-month periods ended March 31, 2019 and 2018. Results of operations for interim periods are not necessarily indicative of results for the entire year. As a result, these financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's annual report on Form 10-K for the year ended December 31, 2018 (2018 Annual Report). |
||||||||||||||||||||||||||||||||||||
| Reclassifications | Reclassifications: Certain reclassifications have been made to prior-year amounts to conform to current-year reporting classifications. These reclassifications had no impact on net earnings or total shareholders' equity. |
||||||||||||||||||||||||||||||||||||
| Recently Adopted Accounting Pronouncements | Recently Adopted Accounting Pronouncements
|
||||||||||||||||||||||||||||||||||||
| Description of Accounting Pronouncements Pending Adoption | Accounting Pronouncements Pending Adoption
|
||||||||||||||||||||||||||||||||||||
BUSINESS SEGMENT INFORMATION (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Segment Reporting [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reconciliation of Revenue from Segments to Consolidated | Information regarding operations by reportable segment and Corporate and other, follows:
(1) Amortized hedge costs of $62 and $55 for the three-month periods ended March 31, 2019, and 2018, respectively, related to certain foreign currency exposure management strategies have been reclassified from realized investment gains (losses) and reported as a deduction from net investment income when analyzing operations. (2) Amortized hedge income of $20 and $2 for the three-month periods ended March 31, 2019, and 2018, respectively, related to certain foreign currency exposure management strategies has been reclassified from realized investment gains (losses) and reported as an increase to net investment income when analyzing operations. (3) Net interest cash flows from derivatives associated with certain investment strategies of $(7) for the three-month period ended March 31, 2019 and an immaterial amount in 2018, respectively, have been reclassified from realized investment gains (losses) and included in adjusted earnings as a component of net investment income. |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reconciliation of Adjusted Profit (Loss) from Segments to Consolidated |
(1) Amortized hedge costs of $62 and $55 for the three-month periods ended March 31, 2019, and 2018, respectively, related to certain foreign currency management strategies have been reclassified from realized investment gains (losses) and reported as a deduction from pretax adjusted earnings when analyzing operations. (2) Amortized hedge income of $20 and $2 for the three-month periods ended March 31, 2019, and 2018, respectively, related to certain foreign currency management strategies has been reclassified from realized investment gains (losses) and reported as an increase in pretax adjusted earnings when analyzing operations. (3) Net interest cash flows from derivatives associated with certain investment strategies of $(7) for the three-month period ended March 31, 2019 and an immaterial amount in 2018, respectively, have been reclassified from realized investment gains (losses) and included in adjusted earnings as a component of net investment income. (4) A gain of $17 and $17 for the three-month periods ended March 31, 2019, and 2018, respectively, related to the interest rate component of the change in fair value of foreign currency swaps on notes payable have been reclassified from realized investment gains (losses) and included in adjusted earnings when analyzing operations |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reconciliation of Assets from Segment to Consolidated | Assets were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
INVESTMENTS (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Available-for-Sale Debt Securities | The amortized cost for the Company's investments in fixed maturity securities, the cost for equity securities and the fair values of these investments are shown in the following tables.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Held-to-maturity Securities |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Equity securities, FV-NI |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments Classified by Contractual Maturity Date | The contractual and economic maturities of the Company's investments in fixed maturity securities at March 31, 2019, were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investment Exposures Exceeding Ten Percent Shareholders Equity | Investment exposures that individually exceeded 10% of shareholders' equity were as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Gain (Loss) on Investments | Information regarding pretax realized gains and losses from investments is as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Net Effect on Shareholders' Equity of Unrealized Gains and Losses from Investment Securities | The net effect on shareholders’ equity of unrealized gains and losses from fixed maturity securities was as follows:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments Gross Unrealized Loss Aging | The following tables show the fair values and gross unrealized losses of the Company's available-for-sale and held-to-maturity investments that were in an unrealized loss position, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Composition of Commercial Mortgage and Other Loans | The following table reflects the composition of commercial mortgage and other loans by portfolio segment as of the periods presented.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Allowance for Loan Losses by Portfolio Segment | The following table presents the rollforward of the allowance for loan losses by portfolio segment during the three-month period ended March 31.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Other Investments | The table below reflects the composition of the carrying value for other investments as of the periods presented.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Securities Lending Transactions Accounted for as Secured Borrowings | Details of collateral by loaned security type and remaining maturity of the agreements were as follows:
(1) The related loaned security, under the Company's U.S. securities lending program, can be returned to the Company at the transferee's discretion; therefore, they are classified as Overnight and Continuous.
(1) The related loaned security, under the Company's U.S. securities lending program, can be returned to the Company at the transferee's discretion; therefore, they are classified as Overnight and Continuous |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Variable Interest Entity, Consolidated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments in Variable Interest Entities | VIEs - Consolidated The following table presents the cost or amortized cost, fair value and balance sheet caption in which the assets and liabilities of consolidated VIEs are reported. Investments in Consolidated Variable Interest Entities
(1) Consists entirely of alternative investments in limited partnerships (2) Consists entirely of derivatives
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Variable Interest Entity, Not Consolidated | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Investments in Variable Interest Entities | VIEs - Not Consolidated The table below reflects the amortized cost, fair value and balance sheet caption in which the Company's investment in VIEs not consolidated are reported. Investments in Variable Interest Entities Not Consolidated
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DERIVATIVE INSTRUMENTS (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments in Statement of Financial Position, Fair Value |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Fair Value Hedging Instruments, Statements of Financial Performance and Financial Position, Location | The following table presents the gains and losses on derivatives and the related hedged items in fair value hedges. Fair Value Hedging Relationships
(1) Gains (losses) excluded from effectiveness testing includes the forward point on foreign currency forwards and time value change on foreign currency options which are reported in the consolidated statement of earnings as realized investment gains (losses). It also includes the change in the fair value of the interest rate swaptions related to the time value of the swaptions which is recognized as a component of other comprehensive income (loss). (2) Gains and losses on foreign currency forwards and options and related hedged items are reported in the consolidated statement of earnings as realized investment gains (losses). For interest rate swaptions and related hedged items, gains and losses included in the hedge assessment are reported within net investment income. For the three-month period ended March 31, 2019, those gains and losses on interest rate swaptions and related hedged items were immaterial.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Interest Rate Fair Value Hedges Hedged Items | The following table shows the carrying amounts of assets designated and qualifying as hedged items in fair value hedges of interest rate risk and the related cumulative hedge adjustment included in the carrying amount.
(1) The balance includes hedging adjustment on discontinued hedging relationships of $276 in 2019 and $294 in 2018. The total notional amount of the Company's interest rate swaptions was $1,500 in 2019 and $500 in 2018. The hedging adjustment related to these derivatives was immaterial.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance | The following table summarizes the impact to realized investment gains (losses) and other comprehensive income (loss) from all derivatives and hedging instruments.
(1) Net investment income (loss) includes net interest on swaps. (2) Cash flow hedge items and the change in the fair value of interest rate swaptions related to the time value of the swaptions in fair value hedges are recorded as unrealized gains (losses) on derivatives and net investment hedge items are recorded in the unrealized foreign currency translation gains (losses) line in the consolidated statement of comprehensive income (loss). (3) Impact of cash flow hedges reported as realized investment gains (losses) includes an immaterial amount of gains or losses reclassified from accumulated other comprehensive income (loss) into earnings. It also includes an immaterial amount excluded from effectiveness testing during the three-month periods ended March 31, 2019 and 2018, respectively. (4)Impact shown net of effect of hedged items (see Fair Value Hedges section of this Note 4 for further detail)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting Assets | Offsetting of Financial Assets and Derivative Asset
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Offsetting Liabilities | Offsetting of Financial Liabilities and Derivative Liabilities
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
FAIR VALUE MEASUREMENTS (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Hierarchy, Assets and Liabilities Measured on Recurring Basis | The following tables present the fair value hierarchy levels of the Company's assets and liabilities that are measured and carried at fair value on a recurring basis.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Hierarchy Levels of Assets and Liabilities Carried at Cost or Amortized Cost | The following tables present the carrying amount and fair value categorized by fair value hierarchy level for the Company's financial instruments that are not carried at fair value.
(1) Excludes policy loans of $236 and equity method investments of $434, at carrying value
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Assets Securities Carried At Fair Value Primary Pricing Sources |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Assets Held-To-Maturity Securities Primary Pricing Sources |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation | The following tables present the changes in fair value of the Company's investments and derivatives carried at fair value classified as Level 3.
(1) Derivative assets and liabilities are presented net (2) Transfer due to sector classification change (3) Transfer due to availability of observable market inputs
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Measurement Inputs and Valuation Techniques | Level 3 Significant Unobservable Input Sensitivity The following tables summarize the significant unobservable inputs used in the valuation of the Company's Level 3 investments and derivatives carried at fair value. Included in the tables are the inputs or range of possible inputs that have an effect on the overall valuation of the financial instruments.
(a) N/A represents securities where the Company receives unadjusted broker quotes and for which there is no transparency into the providers' valuation techniques or unobservable inputs. (b) Inputs derived from U.S. long-term rates to accommodate long maturity nature of the Company's swaps (c) Inputs derived from Japan long-term rates to accommodate long maturity nature of the Company's swaps
(a) N/A represents securities where the Company receives unadjusted broker quotes and for which there is no transparency into the providers' valuation techniques or unobservable inputs. (b) Inputs derived from U.S. long-term rates to accommodate long maturity nature of the Company's swaps (c) Inputs derived from Japan long-term rates to accommodate long maturity nature of the Company's swaps
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
POLICY LIABILITIES (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Insurance Loss Reserves [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Liability for Unpaid Claims Adjustment Expense | Changes in the liability for unpaid policy claims were as follows:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
REINSURANCE (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reinsurance Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Effects of Reinsurance | The following table reconciles direct premium income and direct benefits and claims to net amounts after the effect of reinsurance.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NOTES PAYABLE AND LEASE OBLIGATIONS (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Long-term Debt Instruments | A summary of notes payable and lease obligations follows:
(1) See Note 1 of the Notes to the Consolidated Financial Statements for the adoption of accounting guidance on January 1, 2019 related to leases. Amounts in the table above are reported net of debt issuance costs and issuance premiums or discounts, if applicable, that are being amortized over the life of the notes.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Lease Maturities | The following table presents the contractual maturities and present value of lease liabilities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lease, Cost | The following table presents the weighted average remaining lease term and weighted average discount rate for lease liabilities.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Line of Credit Facilities | A summary of the Company's lines of credit as of March 31, 2019 follows:
(1) Intercompany credit agreement (2) Renewed in April 2019 with an expiration date of April 2, 2020 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHAREHOLDERS' EQUITY (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stockholders' Equity Note [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Common Stock Outstanding Roll Forward | The following table is a reconciliation of the number of shares of the Company's common stock for the three-month periods ended March 31.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share | The following table presents the approximate number of share-based awards to purchase shares, on a weighted-average basis, that were considered to be anti-dilutive and were excluded from the calculation of diluted earnings per share for the following periods.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Accumulated Other Comprehensive Income (Loss) | Reclassifications from Accumulated Other Comprehensive Income The tables below are reconciliations of accumulated other comprehensive income by component for the following periods. Changes in Accumulated Other Comprehensive Income
All amounts in the table above are net of tax.
(1) Includes amounts reclassified due to changes in accounting principles of $(148) related to financial instruments and $374 related to tax effects from tax reform All amounts in the table above are net of tax.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Reclassification Out Of Accumulated Other Comprehensive Income | The tables below summarize the amounts reclassified from each component of accumulated other comprehensive income into net earnings for the following periods. Reclassifications Out of Accumulated Other Comprehensive Income
(1) Based on 25% blended tax rate (2) These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 11 for additional details).
(1) Based on 27% blended tax rate (2) These accumulated other comprehensive income components are included in the computation of net periodic pension cost (see Note 11 for additional details).
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
SHARE-BASED COMPENSATION (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Stock Options Outstanding and Exercisable | The following table provides information on stock options outstanding and exercisable at March 31, 2019.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Nonvested Restricted Stock Units Activity | The following table summarizes restricted stock activity during the three-month period ended March 31.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
BENEFIT PLANS (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Defined Benefit Plans and Other Postretirement Benefit Plans Disclosures [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Net Benefit Costs | Pension and other postretirement benefit expenses are included in acquisition and operating expenses in the consolidated statement of earnings, which includes other components of net periodic pension cost and postretirement costs (other than service costs) of $5 million for both the periods ended March 31, 2019 and 2018. Total net periodic cost includes the following components:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
Jan. 01, 2019 |
Dec. 31, 2018 |
|
| Aflac Japan | ||||
| Significant Accounting Policies [Line Items] | ||||
| Percentage of the Company's total assets | 84.00% | 84.00% | ||
| Percentage of the Company's total revenues | 68.00% | 71.00% | ||
| Accounting Standards Update 2016-02 | ||||
| Significant Accounting Policies [Line Items] | ||||
| New accounting pronouncement or change in accounting principle, cumulative effect of change on assets | $ 134 | |||
| New accounting pronouncement or change in accounting principle, cumulative effect of change on liabilities | $ 134 | |||
BUSINESS SEGMENT INFORMATION - Operations by Segment - Revenues (Details) $ in Millions |
3 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|
|
Mar. 31, 2019
USD ($)
segment
|
Mar. 31, 2018
USD ($)
|
|||||||
| Segment Reporting, Revenue Reconciling Item [Line Items] | ||||||||
| Number of Reportable Insurance Business Segments | segment | 2 | |||||||
| Net earned premiums | $ 4,691 | $ 4,745 | ||||||
| Net investment income | 878 | 837 | ||||||
| Total adjusted revenues | 5,537 | 5,546 | ||||||
| Realized investment gains (losses) | [1],[2],[3] | 120 | (82) | |||||
| Total revenues | 5,657 | 5,464 | ||||||
| Net interest cash flows from derivatives | (7) | |||||||
| Aflac Japan | ||||||||
| Segment Reporting, Revenue Reconciling Item [Line Items] | ||||||||
| Net earned premiums | 3,180 | 3,263 | ||||||
| Net investment income, less amortized hedge costs | 610 | 588 | ||||||
| Other income (loss) | 12 | 12 | ||||||
| Total revenues | 3,802 | 3,863 | ||||||
| Hedge costs | 62 | 55 | ||||||
| Aflac U.S. | ||||||||
| Segment Reporting, Revenue Reconciling Item [Line Items] | ||||||||
| Net earned premiums | 1,461 | 1,427 | ||||||
| Net investment income | 177 | 175 | ||||||
| Other income (loss) | 2 | 2 | ||||||
| Total revenues | 1,640 | 1,604 | ||||||
| Corporate and other | ||||||||
| Segment Reporting, Revenue Reconciling Item [Line Items] | ||||||||
| Total revenues | 95 | 79 | ||||||
| Hedge income | $ 20 | $ 2 | ||||||
| ||||||||
BUSINESS SEGMENT INFORMATION - Operations by Segment - Pretax Earnings (Details) - USD ($) $ in Millions |
3 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|||||||||
| Segment Reporting, Reconciling Item for Adjusted Profit (Loss) from Segment to Consolidated [Line Items] | ||||||||||
| Pretax adjusted earnings | $ 1,139 | $ 1,109 | ||||||||
| Realized investment gains (losses) | [1],[2],[3],[4] | 103 | (98) | |||||||
| Other income (loss) | 0 | (29) | ||||||||
| Earnings before income taxes | 1,242 | 982 | ||||||||
| Income taxes applicable to pretax adjusted earnings | 291 | 289 | ||||||||
| Effect of foreign currency translation on after tax adjusted earnings | (8) | 21 | ||||||||
| Net interest cash flows from derivatives | (7) | |||||||||
| Gain (loss) on change in fair value of derivative, interest rate component | 17 | 17 | ||||||||
| Aflac Japan | ||||||||||
| Segment Reporting, Reconciling Item for Adjusted Profit (Loss) from Segment to Consolidated [Line Items] | ||||||||||
| Pretax adjusted earnings | 834 | 818 | ||||||||
| Hedge costs | 62 | 55 | ||||||||
| Aflac U.S. | ||||||||||
| Segment Reporting, Reconciling Item for Adjusted Profit (Loss) from Segment to Consolidated [Line Items] | ||||||||||
| Pretax adjusted earnings | 323 | 337 | ||||||||
| Corporate and other | ||||||||||
| Segment Reporting, Reconciling Item for Adjusted Profit (Loss) from Segment to Consolidated [Line Items] | ||||||||||
| Pretax adjusted earnings | (18) | (46) | ||||||||
| Hedge income | $ 20 | $ 2 | ||||||||
| ||||||||||
BUSINESS SEGMENT INFORMATION - Operations by Segment - Assets (Detail) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Segment Reporting, Asset Reconciling Item [Line Items] | ||
| Assets | $ 145,679 | $ 140,406 |
| Aflac Japan | ||
| Segment Reporting, Asset Reconciling Item [Line Items] | ||
| Assets | 123,042 | 118,342 |
| Aflac U.S. | ||
| Segment Reporting, Asset Reconciling Item [Line Items] | ||
| Assets | 19,965 | 19,100 |
| Corporate and other | ||
| Segment Reporting, Asset Reconciling Item [Line Items] | ||
| Assets | $ 2,672 | $ 2,964 |
INVESTMENTS - Available-for-sale Debt Securities (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | $ 78,706 | $ 76,856 |
| Gross Unrealized Gains | 10,026 | 7,733 |
| Gross Unrealized Losses | 808 | 1,694 |
| Fair Value | 87,924 | 82,895 |
| Yen-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 45,249 | 44,027 |
| Gross Unrealized Gains | 6,763 | 5,308 |
| Gross Unrealized Losses | 164 | 435 |
| Fair Value | 51,848 | 48,900 |
| Dollar-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 33,457 | 32,829 |
| Gross Unrealized Gains | 3,263 | 2,425 |
| Gross Unrealized Losses | 644 | 1,259 |
| Fair Value | 36,076 | 33,995 |
| Japan government and agencies | Yen-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 31,238 | 30,637 |
| Gross Unrealized Gains | 4,813 | 3,700 |
| Gross Unrealized Losses | 2 | 140 |
| Fair Value | 36,049 | 34,197 |
| Municipalities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Fair Value | 1,908 | 1,863 |
| Municipalities | Yen-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 509 | 385 |
| Gross Unrealized Gains | 93 | 32 |
| Gross Unrealized Losses | 3 | 9 |
| Fair Value | 599 | 408 |
| Municipalities | Dollar-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 1,204 | 1,343 |
| Gross Unrealized Gains | 105 | 120 |
| Gross Unrealized Losses | 0 | 8 |
| Fair Value | 1,309 | 1,455 |
| Mortgage- and asset-backed securities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Fair Value | 414 | 339 |
| Mortgage- and asset-backed securities | Yen-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 233 | 155 |
| Gross Unrealized Gains | 27 | 22 |
| Gross Unrealized Losses | 0 | 0 |
| Fair Value | 260 | 177 |
| Mortgage- and asset-backed securities | Dollar-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 147 | 155 |
| Gross Unrealized Gains | 7 | 8 |
| Gross Unrealized Losses | 0 | 1 |
| Fair Value | 154 | 162 |
| Public utilities | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Fair Value | 6,497 | 7,171 |
| Public utilities | Yen-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 1,822 | 1,732 |
| Gross Unrealized Gains | 344 | 280 |
| Gross Unrealized Losses | 0 | 4 |
| Fair Value | 2,166 | 2,008 |
| Public utilities | Dollar-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 3,841 | 4,772 |
| Gross Unrealized Gains | 522 | 496 |
| Gross Unrealized Losses | 32 | 105 |
| Fair Value | 4,331 | 5,163 |
| Sovereign and supranational | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Fair Value | 1,154 | 1,260 |
| Sovereign and supranational | Yen-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 740 | 826 |
| Gross Unrealized Gains | 65 | 123 |
| Gross Unrealized Losses | 0 | 0 |
| Fair Value | 805 | 949 |
| Sovereign and supranational | Dollar-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 276 | 251 |
| Gross Unrealized Gains | 73 | 60 |
| Gross Unrealized Losses | 0 | 0 |
| Fair Value | 349 | 311 |
| Banks/financial institutions | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Fair Value | 9,391 | 8,918 |
| Banks/financial institutions | Yen-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 5,664 | 5,440 |
| Gross Unrealized Gains | 597 | 502 |
| Gross Unrealized Losses | 139 | 238 |
| Fair Value | 6,122 | 5,704 |
| Banks/financial institutions | Dollar-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 2,798 | 2,860 |
| Gross Unrealized Gains | 484 | 389 |
| Gross Unrealized Losses | 13 | 35 |
| Fair Value | 3,269 | 3,214 |
| Other corporate | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Fair Value | 32,311 | 29,002 |
| Other corporate | Yen-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 5,043 | 4,852 |
| Gross Unrealized Gains | 824 | 649 |
| Gross Unrealized Losses | 20 | 44 |
| Fair Value | 5,847 | 5,457 |
| Other corporate | Dollar-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 25,001 | 23,311 |
| Gross Unrealized Gains | 2,061 | 1,343 |
| Gross Unrealized Losses | 598 | 1,109 |
| Fair Value | 26,464 | 23,545 |
| U.S. government and agencies | Dollar-denominated | ||
| Debt Securities, Available-for-sale [Line Items] | ||
| Cost or Amortized Cost | 190 | 137 |
| Gross Unrealized Gains | 11 | 9 |
| Gross Unrealized Losses | 1 | 1 |
| Fair Value | $ 200 | $ 145 |
INVESTMENTS - Held-to-Maturity Debt Securities (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | $ 30,163 | $ 30,318 |
| Gross Unrealized Gains | 7,298 | 6,470 |
| Gross Unrealized Losses | 15 | 66 |
| Fair Value | 37,446 | 36,722 |
| Yen-denominated | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 30,163 | 30,318 |
| Gross Unrealized Gains | 7,298 | 6,470 |
| Gross Unrealized Losses | 15 | 66 |
| Fair Value | 37,446 | 36,722 |
| Japan government and agencies | Yen-denominated | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 21,961 | 21,712 |
| Gross Unrealized Gains | 6,018 | 5,326 |
| Gross Unrealized Losses | 0 | 0 |
| Fair Value | 27,979 | 27,038 |
| Municipalities | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 814 | 359 |
| Fair Value | 1,061 | 469 |
| Municipalities | Yen-denominated | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 814 | 359 |
| Gross Unrealized Gains | 247 | 110 |
| Gross Unrealized Losses | 0 | 0 |
| Fair Value | 1,061 | 469 |
| Mortgage- and asset-backed securities | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 20 | 14 |
| Fair Value | 21 | 15 |
| Mortgage- and asset-backed securities | Yen-denominated | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 20 | 14 |
| Gross Unrealized Gains | 1 | 1 |
| Gross Unrealized Losses | 0 | 0 |
| Fair Value | 21 | 15 |
| Public utilities | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 2,728 | 2,727 |
| Fair Value | 3,068 | 2,973 |
| Public utilities | Yen-denominated | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 2,728 | 2,727 |
| Gross Unrealized Gains | 340 | 254 |
| Gross Unrealized Losses | 0 | 8 |
| Fair Value | 3,068 | 2,973 |
| Sovereign and supranational | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 1,154 | 1,551 |
| Fair Value | 1,332 | 1,840 |
| Sovereign and supranational | Yen-denominated | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 1,154 | 1,551 |
| Gross Unrealized Gains | 178 | 289 |
| Gross Unrealized Losses | 0 | 0 |
| Fair Value | 1,332 | 1,840 |
| Banks/financial institutions | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 949 | 1,445 |
| Fair Value | 1,039 | 1,583 |
| Banks/financial institutions | Yen-denominated | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 949 | 1,445 |
| Gross Unrealized Gains | 100 | 158 |
| Gross Unrealized Losses | 10 | 20 |
| Fair Value | 1,039 | 1,583 |
| Other corporate | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 2,537 | 2,510 |
| Fair Value | 2,946 | 2,804 |
| Other corporate | Yen-denominated | ||
| Schedule of Held-to-maturity Securities [Line Items] | ||
| Securities held to maturity, fixed maturities, amortized cost | 2,537 | 2,510 |
| Gross Unrealized Gains | 414 | 332 |
| Gross Unrealized Losses | 5 | 38 |
| Fair Value | $ 2,946 | $ 2,804 |
INVESTMENTS - Equity Securities (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Equity Securities, FV-NI [Line Items] | ||
| Fair Value | $ 1,041 | $ 987 |
| Yen-denominated | ||
| Equity Securities, FV-NI [Line Items] | ||
| Fair Value | 662 | 641 |
| Dollar-denominated | ||
| Equity Securities, FV-NI [Line Items] | ||
| Fair Value | $ 379 | $ 346 |
INVESTMENTS - Contractual and Economic Maturities of Investments in Fixed Maturities (Detail) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Available for sale: | ||
| Due in one year or less | $ 889 | |
| Due after one year through five years | 8,483 | |
| Due after five years through 10 years | 10,111 | |
| Due after 10 years | 58,843 | |
| Mortgage- and asset-backed securities | 380 | |
| Total fixed maturity securities, available for sale, amortized cost | 78,706 | $ 76,856 |
| Held to maturity: | ||
| Due in one year or less | 135 | |
| Due after one year through five years | 1,112 | |
| Due after five years through 10 years | 678 | |
| Due after 10 years | 28,218 | |
| Mortgage- and asset-backed securities | 20 | |
| Total fixed maturity securities, held to maturity, amortized cost | 30,163 | 30,318 |
| Available for sale: | ||
| Due in one year or less | 950 | |
| Due after one year through five years | 8,624 | |
| Due after five years through 10 years | 11,034 | |
| Due after 10 years | 66,902 | |
| Mortgage- and asset-backed securities | 414 | |
| Total fixed maturity securities, available for sale, fair value | 87,924 | 82,895 |
| Held to maturity: | ||
| Due in one year or less | 137 | |
| Due after one year through five years | 1,187 | |
| Due after five years through 10 years | 739 | |
| Due after 10 years | 35,362 | |
| Mortgage- and asset-backed securities | 21 | |
| Total fixed maturity securities, held to maturity, fair value | $ 37,446 | $ 36,722 |
INVESTMENTS - Investment Exposures Individually Exceeded 10% of Shareholders' Equity (Details) - Japan National Government - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
||||
| Summary of Investment Holdings [Line Items] | |||||
| Credit Rating | [1] | A+ | A+ | ||
| Amortized Cost | [1] | $ 51,775 | $ 51,207 | ||
| Fair Value | [1] | $ 62,275 | $ 59,945 | ||
| |||||
INVESTMENTS - Information Regarding Pretax Realized Gains and Losses From Investments (Detail) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Gain (Loss) on Securities [Line Items] | ||
| Other-than-temporary impairment losses realized | $ (2) | $ (7) |
| Loan loss reserves | (2) | (7) |
| Derivative gains (losses) | 0 | 144 |
| Foreign currency gains (losses) | (2) | (228) |
| Total realized investment gains (losses) | 71 | (134) |
| Loan receivables | ||
| Gain (Loss) on Securities [Line Items] | ||
| Total realized investment gains (losses) | (2) | (7) |
| Derivatives and other | ||
| Gain (Loss) on Securities [Line Items] | ||
| Total realized investment gains (losses) | (2) | (84) |
| Equity securities | ||
| Gain (Loss) on Securities [Line Items] | ||
| Total realized investment gains (losses) | 58 | (46) |
| Available-for-sale securities | Fixed maturities | ||
| Gain (Loss) on Securities [Line Items] | ||
| Gross gains from sales | 12 | 10 |
| Gross losses from sales | (8) | (2) |
| Foreign currency gains (losses) on sales and redemptions | 13 | (5) |
| Total realized investment gains (losses) | $ 17 | $ 3 |
INVESTMENTS - Net Effect on Shareholders' Equity of Unrealized Gains and Losses from Investment Securities (Detail) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
|
| Investments [Abstract] | ||
| Unrealized gains (losses) on securities available-for-sale | $ 9,218 | $ 6,039 |
| Deferred income taxes | (2,657) | (1,805) |
| Shareholders' equity, unrealized gains (losses) on fixed maturity securities | $ 6,561 | $ 4,234 |
INVESTMENTS - Fair Value and Gross Unrealized Losses for Securities That Have Been in Continuous Unrealized Loss Position (Detail) - Fixed maturity securities - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended |
|---|---|---|
Mar. 31, 2019 |
Dec. 31, 2018 |
|
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | $ 13,416 | $ 24,484 |
| Total Unrealized Losses | 823 | 1,760 |
| Less than 12 months Fair Value | 6,745 | 16,389 |
| Less than 12 months Unrealized Losses | 417 | 985 |
| 12 months or longer Fair Value | 6,671 | 8,095 |
| 12 months or longer Unrealized Losses | 406 | 775 |
| Dollar-denominated | U.S. government and agencies | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 65 | 67 |
| Total Unrealized Losses | 1 | 1 |
| Less than 12 months Fair Value | 65 | 67 |
| Less than 12 months Unrealized Losses | 1 | 1 |
| 12 months or longer Fair Value | 0 | 0 |
| 12 months or longer Unrealized Losses | 0 | 0 |
| Dollar-denominated | Municipalities | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 515 | |
| Total Unrealized Losses | 8 | |
| Less than 12 months Fair Value | 515 | |
| Less than 12 months Unrealized Losses | 8 | |
| 12 months or longer Fair Value | 0 | |
| 12 months or longer Unrealized Losses | 0 | |
| Dollar-denominated | Mortgage- and asset-backed securities | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 53 | 74 |
| Total Unrealized Losses | 0 | 1 |
| Less than 12 months Fair Value | 53 | 74 |
| Less than 12 months Unrealized Losses | 0 | 1 |
| 12 months or longer Fair Value | 0 | 0 |
| 12 months or longer Unrealized Losses | 0 | 0 |
| Dollar-denominated | Public utilities | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 808 | 1,585 |
| Total Unrealized Losses | 32 | 105 |
| Less than 12 months Fair Value | 306 | 892 |
| Less than 12 months Unrealized Losses | 14 | 48 |
| 12 months or longer Fair Value | 502 | 693 |
| 12 months or longer Unrealized Losses | 18 | 57 |
| Dollar-denominated | Banks/financial institutions | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 345 | 625 |
| Total Unrealized Losses | 13 | 35 |
| Less than 12 months Fair Value | 209 | 340 |
| Less than 12 months Unrealized Losses | 10 | 19 |
| 12 months or longer Fair Value | 136 | 285 |
| 12 months or longer Unrealized Losses | 3 | 16 |
| Dollar-denominated | Other corporate | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 9,182 | 12,899 |
| Total Unrealized Losses | 598 | 1,109 |
| Less than 12 months Fair Value | 3,149 | 5,782 |
| Less than 12 months Unrealized Losses | 213 | 407 |
| 12 months or longer Fair Value | 6,033 | 7,117 |
| 12 months or longer Unrealized Losses | 385 | 702 |
| Yen-denominated | Japan government and agencies | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 139 | 3,604 |
| Total Unrealized Losses | 2 | 140 |
| Less than 12 months Fair Value | 139 | 3,604 |
| Less than 12 months Unrealized Losses | 2 | 140 |
| 12 months or longer Fair Value | 0 | 0 |
| 12 months or longer Unrealized Losses | 0 | 0 |
| Yen-denominated | Municipalities | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 70 | 148 |
| Total Unrealized Losses | 3 | 9 |
| Less than 12 months Fair Value | 70 | 148 |
| Less than 12 months Unrealized Losses | 3 | 9 |
| 12 months or longer Fair Value | 0 | 0 |
| 12 months or longer Unrealized Losses | 0 | 0 |
| Yen-denominated | Public utilities | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 604 | |
| Total Unrealized Losses | 12 | |
| Less than 12 months Fair Value | 604 | |
| Less than 12 months Unrealized Losses | 12 | |
| 12 months or longer Fair Value | 0 | |
| 12 months or longer Unrealized Losses | 0 | |
| Yen-denominated | Banks/financial institutions | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 2,229 | 3,057 |
| Total Unrealized Losses | 149 | 258 |
| Less than 12 months Fair Value | 2,229 | 3,057 |
| Less than 12 months Unrealized Losses | 149 | 258 |
| 12 months or longer Fair Value | 0 | 0 |
| 12 months or longer Unrealized Losses | 0 | 0 |
| Yen-denominated | Other corporate | ||
| Investments, Unrealized Loss Position [Line Items] | ||
| Total Fair Value | 525 | 1,306 |
| Total Unrealized Losses | 25 | 82 |
| Less than 12 months Fair Value | 525 | 1,306 |
| Less than 12 months Unrealized Losses | 25 | 82 |
| 12 months or longer Fair Value | 0 | 0 |
| 12 months or longer Unrealized Losses | $ 0 | $ 0 |
INVESTMENTS - Commercial Mortgage and Other Loans by Portfolio Segment (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Commercial Mortgage and Other Loans | ||
| Gross commercial mortgage and other loans | $ 7,209 | $ 6,946 |
| Valuation allowance | (29) | (27) |
| Commercial mortgage and other loans | 7,180 | 6,919 |
| Transitional real estate loans | ||
| Commercial Mortgage and Other Loans | ||
| Gross commercial mortgage and other loans | 4,398 | 4,394 |
| Valuation allowance | (18) | (17) |
| Commercial mortgage loans | ||
| Commercial Mortgage and Other Loans | ||
| Gross commercial mortgage and other loans | 1,085 | 1,065 |
| Valuation allowance | (1) | (1) |
| Middle market loans | ||
| Commercial Mortgage and Other Loans | ||
| Gross commercial mortgage and other loans | 1,726 | 1,487 |
| Valuation allowance | $ (10) | $ (9) |
INVESTMENTS - Allowance for Loan Losses by Portfolio Segment (Details) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Allowance for Loan Losses by Portfolio Segment [Roll Forward] | ||
| Balance, beginning of period | $ (27) | |
| Addition to (release of) allowance for credit losses | (2) | $ (7) |
| Balance, end of period | (29) | |
| Commercial mortgage loans | ||
| Allowance for Loan Losses by Portfolio Segment [Roll Forward] | ||
| Balance, beginning of period | (1) | |
| Addition to (release of) allowance for credit losses | 0 | |
| Balance, end of period | (1) | |
| Transitional real estate loans | ||
| Allowance for Loan Losses by Portfolio Segment [Roll Forward] | ||
| Balance, beginning of period | (17) | |
| Addition to (release of) allowance for credit losses | (1) | |
| Balance, end of period | (18) | |
| Middle market loans | ||
| Allowance for Loan Losses by Portfolio Segment [Roll Forward] | ||
| Balance, beginning of period | (9) | |
| Addition to (release of) allowance for credit losses | (1) | |
| Balance, end of period | $ (10) | |
INVESTMENTS - Other Investments (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
||
|---|---|---|---|---|
| Investment Holdings [Line Items] | ||||
| Other investments | $ 1,238 | $ 787 | ||
| Policy loans | ||||
| Investment Holdings [Line Items] | ||||
| Other investments | 236 | 232 | ||
| Short-term investments | ||||
| Investment Holdings [Line Items] | ||||
| Other investments | [1] | 543 | 152 | |
| Limited partnerships | ||||
| Investment Holdings [Line Items] | ||||
| Other investments | 434 | 377 | ||
| Other | ||||
| Investment Holdings [Line Items] | ||||
| Other investments | $ 25 | $ 26 | ||
| ||||
INVESTMENTS - Investments in Consolidated Variable Interest Entities (Detail) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|||||
|---|---|---|---|---|---|---|---|
| Variable Interest Entity [Line Items] | |||||||
| Available for sale, fixed maturity securities, amortized cost | $ 78,706 | $ 76,856 | |||||
| Available for sale, fixed maturity securities | 87,924 | 82,895 | |||||
| Equity securities | 1,041 | 987 | |||||
| Commercial mortgage and other loans | 7,180 | 6,919 | |||||
| Commercial mortgage and other loans, fair value | 7,185 | 6,893 | |||||
| Other investments | 1,238 | 787 | |||||
| Asset derivatives | 401 | 417 | |||||
| Assets, fair value | 93,801 | 88,788 | |||||
| Liability derivatives | 365 | 387 | |||||
| Liabilities | 119,630 | 116,944 | |||||
| Liabilities, fair value | 365 | 387 | |||||
| Variable Interest Entity, Consolidated | |||||||
| Variable Interest Entity [Line Items] | |||||||
| Available for sale, fixed maturity securities, amortized cost | 3,756 | 3,849 | |||||
| Available for sale, fixed maturity securities | 4,543 | 4,466 | |||||
| Equity securities, FV-NI, cost | 180 | 160 | |||||
| Equity securities | 180 | 160 | |||||
| Commercial mortgage and other loans | 5,892 | 5,528 | |||||
| Commercial mortgage and other loans, fair value | 5,894 | 5,506 | |||||
| Other investments | [1] | 374 | 328 | ||||
| Other investments, fair value | [1] | 374 | 328 | ||||
| Asset derivatives, amortized cost | [2] | 178 | 182 | ||||
| Asset derivatives | [2] | 178 | 182 | ||||
| Assets, amortized cost | 10,380 | 10,047 | |||||
| Assets, fair value | 11,169 | 10,642 | |||||
| Liability derivatives, amortized cost | [2] | 108 | 102 | ||||
| Liability derivatives | [2] | 108 | 102 | ||||
| Liabilities | 108 | 102 | |||||
| Liabilities, fair value | $ 108 | $ 102 | |||||
| |||||||
INVESTMENTS - Investments in Variable Interest Entities Not Consolidated (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|||
|---|---|---|---|---|---|
| Variable Interest Entity [Line Items] | |||||
| Available for sale, fixed maturity securities, amortized cost | $ 78,706 | $ 76,856 | |||
| Available for sale, fixed maturity securities | 87,924 | 82,895 | |||
| Securities held to maturity, fixed maturities, amortized cost | 30,163 | 30,318 | |||
| Held to maturity, fixed maturity securities, fair value | 37,446 | 36,722 | |||
| Other investments | 1,238 | 787 | |||
| Assets, fair value | 93,801 | 88,788 | |||
| Variable Interest Entity, Not Consolidated | |||||
| Variable Interest Entity [Line Items] | |||||
| Available for sale, fixed maturity securities, amortized cost | 4,455 | 4,575 | |||
| Available for sale, fixed maturity securities | 5,025 | 4,982 | |||
| Securities held to maturity, fixed maturities, amortized cost | 2,006 | 2,007 | |||
| Held to maturity, fixed maturity securities, fair value | 2,331 | 2,254 | |||
| Other investments | [1] | 59 | 49 | ||
| Other investments, fair value | [1] | 59 | 49 | ||
| Assets, amortized cost | 6,520 | 6,631 | |||
| Assets, fair value | $ 7,415 | $ 7,285 | |||
| |||||
INVESTMENTS - Securities Lending Transactions Accounted for as Secured Borrowings (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|||
|---|---|---|---|---|---|
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | $ 3,870 | $ 2,242 | |||
| Gross amount of recognized liabilities for securities lending | 1,969 | 1,052 | |||
| Amounts related to agreements not included in offsetting disclosure in Note 4 | 1,901 | 1,190 | |||
| Japan government and agencies | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 3,002 | 1,577 | |||
| Municipalities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 5 | ||||
| Public utilities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 15 | 27 | |||
| Banks/financial institutions | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 74 | 74 | |||
| Other corporate | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 764 | 549 | |||
| Equity securities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 15 | 10 | |||
| Maturity Overnight and Continuous | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | [1] | 868 | 665 | ||
| Maturity Overnight and Continuous | Japan government and agencies | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | [1] | 0 | 0 | ||
| Maturity Overnight and Continuous | Municipalities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | [1] | 5 | |||
| Maturity Overnight and Continuous | Public utilities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | [1] | 15 | 27 | ||
| Maturity Overnight and Continuous | Banks/financial institutions | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | [1] | 74 | 74 | ||
| Maturity Overnight and Continuous | Other corporate | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | [1] | 764 | 549 | ||
| Maturity Overnight and Continuous | Equity securities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | [1] | 15 | 10 | ||
| Maturity up to 30 Days | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 1,101 | 387 | |||
| Maturity up to 30 Days | Japan government and agencies | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 1,101 | 387 | |||
| Maturity up to 30 Days | Municipalities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | ||||
| Maturity up to 30 Days | Public utilities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | 0 | |||
| Maturity up to 30 Days | Banks/financial institutions | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | 0 | |||
| Maturity up to 30 Days | Other corporate | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | 0 | |||
| Maturity up to 30 Days | Equity securities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | 0 | |||
| Maturity Greater than 90 Days | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 1,901 | 1,190 | |||
| Maturity Greater than 90 Days | Japan government and agencies | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 1,901 | 1,190 | |||
| Maturity Greater than 90 Days | Municipalities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | ||||
| Maturity Greater than 90 Days | Public utilities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | 0 | |||
| Maturity Greater than 90 Days | Banks/financial institutions | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | 0 | |||
| Maturity Greater than 90 Days | Other corporate | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | 0 | 0 | |||
| Maturity Greater than 90 Days | Equity securities | |||||
| Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items] | |||||
| Securities Loaned, Including Not Subject to Master Netting Arrangement and Assets other than Securities Transferred | $ 0 | $ 0 | |||
| |||||
INVESTMENTS - Additional Information (Detail) $ in Millions |
3 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2019
USD ($)
investment
|
Mar. 31, 2018
investment
|
Dec. 31, 2018
USD ($)
|
|
| Schedule of Investments [Line Items] | |||
| Held to maturity securities transferred to available for sale securities, number of investments | investment | 0 | 0 | |
| Equity securities, FV-NI, unrealized gain (loss) | $ 47 | ||
| Transitional real estate loans, average loan-to-value at origination, limit | 70.00% | ||
| Transitional real estate loans, individual loan-to-value at origination, limit | 80.00% | ||
| Transitional real estate loan commitments | $ 733 | ||
| Commercial mortgage loans, average loan-to-value at origination, limit | 65.00% | ||
| Commercial mortgage loans, individual loan-to-value at origination, limit | 70.00% | ||
| Commercial mortgage loan commitments | $ 28 | ||
| Middle market loan program unfunded amount | 127 | $ 56 | |
| Middle market loan commitments | 677 | ||
| Allowance for loan loss | 29 | $ 27 | |
| Limited partnerships investment commitments | $ 915 | ||
| Percentage that the lending policy requires that the fair value of the securities received as collateral be of the fair value of the loaned securities | 102.00% | ||
| Percentage that the lending policy requires that the fair value of the unrestricted cash received as collateral be of the fair value of the loaned securities | 100.00% | ||
DERIVATIVE INSTRUMENTS - Additional Information (Detail) $ in Millions |
Mar. 31, 2019
USD ($)
yr
counterparties
|
Dec. 31, 2018
USD ($)
|
|---|---|---|
| Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
| Cash flow hedging activity, maximum time period | yr | 8 | |
| Number of counterparties | counterparties | 16 | |
| Number of counterparties that comprise majority of aggregate notional amount of swaps | counterparties | 4 | |
| Percentage of notional amount of swaps from certain number of counterparties | 65.00% | |
| Derivative, net liability position, aggregate fair value | $ 133 | $ 139 |
| Additional collateral, aggregate fair value | 23 | |
| 4.00% senior notes due February 2022 | ||
| Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
| Debt instrument, principal amount | 350 | |
| 3.625% senior notes due June 2023 | ||
| Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
| Debt instrument, principal amount | 700 | |
| 3.625% senior notes due November 2024 | ||
| Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
| Debt instrument, principal amount | 750 | |
| 3.25% senior notes due March 2025 | ||
| Derivative Instruments and Hedging Activities Disclosure [Line Items] | ||
| Debt instrument, principal amount | $ 450 |
DERIVATIVE INSTRUMENTS - Summary of Balance Sheet Classification of Derivative Fair Value Amounts, as well as Gross Asset and Liability Fair Value Amounts (Detail) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | $ 39,051 | $ 38,355 |
| Derivative asset, fair value, gross asset including not subject to master netting arrangement | 401 | 417 |
| Derivative liability, fair value, gross liability including not subject to master netting arrangement | 365 | 387 |
| Asset derivatives fair value | 223 | 234 |
| Liability derivatives fair value | 257 | 285 |
| Cash flow hedges | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 75 | 75 |
| Asset derivatives fair value | 0 | 1 |
| Liability derivatives fair value | 6 | 4 |
| Cash flow hedges | Foreign currency swaps | Variable Interest Entity | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 75 | 75 |
| Asset derivatives fair value | 0 | 1 |
| Liability derivatives fair value | 6 | 4 |
| Fair value hedges | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 13,079 | 11,656 |
| Asset derivatives fair value | 0 | 3 |
| Liability derivatives fair value | 27 | 36 |
| Fair value hedges | Foreign currency forwards | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 691 | 2,086 |
| Asset derivatives fair value | 0 | 0 |
| Liability derivatives fair value | 24 | 34 |
| Fair value hedges | Foreign currency options | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 10,887 | 9,070 |
| Asset derivatives fair value | 0 | 3 |
| Liability derivatives fair value | 2 | 1 |
| Fair value hedges | Interest rate swaptions | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 1,500 | 500 |
| Asset derivatives fair value | 0 | 0 |
| Liability derivatives fair value | 1 | 1 |
| Non-qualifying strategies | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 25,897 | 26,624 |
| Asset derivatives fair value | 401 | 413 |
| Liability derivatives fair value | 332 | 347 |
| Non-qualifying strategies | Foreign currency swaps | Variable Interest Entity | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 2,587 | 2,587 |
| Asset derivatives fair value | 178 | 181 |
| Liability derivatives fair value | 102 | 101 |
| Non-qualifying strategies | Foreign currency swaps | Consolidated Entity Excluding Variable Interest Entities (VIE) | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 2,800 | 2,800 |
| Asset derivatives fair value | 96 | 103 |
| Liability derivatives fair value | 98 | 129 |
| Non-qualifying strategies | Foreign currency forwards | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 15,208 | 16,057 |
| Asset derivatives fair value | 119 | 126 |
| Liability derivatives fair value | 132 | 117 |
| Non-qualifying strategies | Foreign currency options | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 552 | 430 |
| Asset derivatives fair value | 0 | 0 |
| Liability derivatives fair value | 0 | 0 |
| Non-qualifying strategies | Interest rate swaps | ||
| Derivatives, Fair Value [Line Items] | ||
| Net derivatives notional amount | 4,750 | 4,750 |
| Asset derivatives fair value | 8 | 3 |
| Liability derivatives fair value | $ 0 | $ 0 |
DERIVATIVE INSTRUMENTS - Gains (Losses) Recognized on Fair Value Hedging Relationships (Details) - USD ($) $ in Millions |
3 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||
| Total gains (losses) recognized for derivatives | $ 4 | $ 413 | |||||
| Gains (losses) on derivatives excluded from effectiveness testing | [1] | (15) | (40) | ||||
| Gains (losses) on derivatives included in effectiveness testing | [2] | 19 | 453 | ||||
| Gains (losses) recognized for hedged items | [2] | (18) | (464) | ||||
| Net realized gains (losses) recognized for fair value hedge | 1 | (11) | |||||
| Fixed maturity securities | Foreign currency forwards | |||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||
| Total gains (losses) recognized for derivatives | 9 | 414 | |||||
| Gains (losses) on derivatives excluded from effectiveness testing | [1] | (10) | (39) | ||||
| Gains (losses) on derivatives included in effectiveness testing | [2] | 19 | 453 | ||||
| Gains (losses) recognized for hedged items | [2] | (18) | (464) | ||||
| Net realized gains (losses) recognized for fair value hedge | 1 | (11) | |||||
| Fixed maturity securities | Foreign currency options | |||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||
| Total gains (losses) recognized for derivatives | (4) | (1) | |||||
| Gains (losses) on derivatives excluded from effectiveness testing | [1] | (4) | (1) | ||||
| Gains (losses) on derivatives included in effectiveness testing | [2] | 0 | 0 | ||||
| Gains (losses) recognized for hedged items | [2] | 0 | 0 | ||||
| Net realized gains (losses) recognized for fair value hedge | 0 | $ 0 | |||||
| Fixed maturity securities | Interest rate swaptions | |||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||
| Total gains (losses) recognized for derivatives | (1) | ||||||
| Gains (losses) on derivatives excluded from effectiveness testing | [1] | (1) | |||||
| Gains (losses) on derivatives included in effectiveness testing | [2] | 0 | |||||
| Gains (losses) recognized for hedged items | [2] | 0 | |||||
| Net realized gains (losses) recognized for fair value hedge | $ 0 | ||||||
| |||||||
DERIVATIVE INSTRUMENTS - Schedule of Interest Rate Fair Value Hedges Hedged Items (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
||
|---|---|---|---|---|
| Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||
| Notional Amount of Derivatives | $ 39,051 | $ 38,355 | ||
| Fair value hedges | ||||
| Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||
| Notional Amount of Derivatives | 13,079 | 11,656 | ||
| Interest rate swaptions | Fair value hedges | ||||
| Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||
| Notional Amount of Derivatives | 1,500 | 500 | ||
| Fixed maturity securities | Interest rate swaptions | ||||
| Derivative Instruments and Hedging Activities Disclosures [Line Items] | ||||
| Carrying Amount of Hedged Assets/ (Liabilities) | [1] | 5,285 | 6,593 | |
| Cumulative Amount of Fair Value Hedging Adjustment Included in the Carrying Amount of Hedged Assets/(Liabilities) | $ 276 | $ 294 | ||
| ||||
DERIVATIVE INSTRUMENTS - Derivatives and Hedging Instruments Gain (Loss) Summary (Details) - USD ($) $ in Millions |
3 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) reclassified from accumulated OCI into income, effective portion, net | [1] | $ (1) | $ 0 | ||||||||
| Unrealized foreign currency translation gains (losses) during period | (1) | 824 | |||||||||
| Derivative gains (losses) | 0 | 144 | |||||||||
| Derivative and non-derivative hedging instruments gain (loss) recognized in other comprehensive income effective portion before tax | [2] | (3) | (86) | ||||||||
| Cash flow hedges | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) reclassified from accumulated OCI into income, effective portion, net | [1] | (1) | 0 | ||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | [3] | 0 | 1 | ||||||||
| Gain (loss) recognized in other comprehensive income on derivative (effective portion) | [2] | (2) | 6 | ||||||||
| Cash flow hedges | Foreign currency swaps | Variable Interest Entity | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) reclassified from accumulated OCI into income, effective portion, net | [1] | (1) | 0 | ||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | 0 | 1 | |||||||||
| Gain (loss) recognized in other comprehensive income on derivative (effective portion) | [2] | (2) | 6 | ||||||||
| Fair value hedges | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) reclassified from accumulated OCI into income, effective portion, net | [1] | 0 | 0 | ||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | (13) | (51) | |||||||||
| Gain (loss) recognized in other comprehensive income on derivative (effective portion) | [2] | (1) | 0 | ||||||||
| Fair value hedges | Foreign currency forwards | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | [4] | (9) | (50) | ||||||||
| Fair value hedges | Foreign currency options | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | [4] | (4) | (1) | ||||||||
| Fair value hedges | Interest rate swaptions | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) reclassified from accumulated OCI into income, effective portion, net | [1] | 0 | 0 | ||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | [4] | 0 | 0 | ||||||||
| Gain (loss) recognized in other comprehensive income on derivative (effective portion) | [2],[4] | (1) | 0 | ||||||||
| Net investment hedge | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | 0 | 0 | |||||||||
| Unrealized foreign currency translation gains (losses) during period | [2] | 0 | (92) | ||||||||
| Net investment hedge | Foreign currency options | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | 0 | 0 | |||||||||
| Unrealized foreign currency translation gains (losses) during period | [2] | 0 | (8) | ||||||||
| Net investment hedge | Non-derivative hedging instruments | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Net realized investment gains (losses) recognized in income on derivative (ineffective portion) | 0 | 0 | |||||||||
| Unrealized foreign currency translation gains (losses) during period | [2] | 0 | (84) | ||||||||
| Non-qualifying strategies | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) recognized in income, net | 13 | 194 | |||||||||
| Non-qualifying strategies | Foreign currency swaps | Variable Interest Entity | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) recognized in income, net | (16) | 124 | |||||||||
| Non-qualifying strategies | Foreign currency swaps | Consolidated Entity Excluding Variable Interest Entities (VIE) | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) recognized in income, net | 44 | (110) | |||||||||
| Non-qualifying strategies | Foreign currency forwards | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) recognized in income, net | (21) | 179 | |||||||||
| Non-qualifying strategies | Foreign currency options | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) recognized in income, net | 0 | 1 | |||||||||
| Non-qualifying strategies | Interest rate swaps | |||||||||||
| Derivative Instruments, Gain (Loss) [Line Items] | |||||||||||
| Derivative instruments, gain (loss) recognized in income, net | $ 6 | $ 0 | |||||||||
| |||||||||||
DERIVATIVE INSTRUMENTS - Offsetting of Financial Assets and Derivative Assets (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Offsetting Assets [Line Items] | ||
| Gross amount of recognized derivative assets | $ 223 | $ 234 |
| Gross amount of liabilities offset in balance sheet | 0 | 0 |
| Net amount of derivative assets presented in balance sheet | 223 | 234 |
| Financial instruments, amount not offset | (118) | (152) |
| Derivative, collateral, obligation to return securities | (10) | (23) |
| Derivative, collateral, obligation to return cash | (81) | (58) |
| Derivative asset, fair value, amount offset against collateral, subject to master netting agreement | 14 | 1 |
| Derivative asset, not subject to master netting arrangement | 178 | 183 |
| Derivative asset, fair value, amount offset against collateral, not subject to master netting agreement | 178 | 183 |
| Derivative asset, fair value, gross asset including not subject to master netting arrangement | 401 | 417 |
| Net amount of derivative assets presented in balance sheet | 401 | 417 |
| Derivative asset, fair value, amount offset against collateral | 192 | 184 |
| Gross amounts of recognized financial instruments | 2,360 | 1,446 |
| Gross amounts offset in balance sheet | 0 | 0 |
| Net amounts of assets presented in balance sheet | 2,360 | 1,446 |
| Carrying value of financial instruments not offset in balance sheet | (118) | (152) |
| Securities collateral, not offset in balance sheet | (10) | (23) |
| Cash collateral, not offset in balance sheet | (2,040) | (1,087) |
| Financial instruments, amount of assets offset against collateral | 192 | 184 |
| Over the Counter - Bilateral | ||
| Offsetting Assets [Line Items] | ||
| Gross amount of recognized derivative assets | 215 | 231 |
| Gross amount of liabilities offset in balance sheet | 0 | 0 |
| Net amount of derivative assets presented in balance sheet | 215 | 231 |
| Financial instruments, amount not offset | (118) | (152) |
| Derivative, collateral, obligation to return securities | (10) | (23) |
| Derivative, collateral, obligation to return cash | (80) | (55) |
| Derivative asset, fair value, amount offset against collateral, subject to master netting agreement | 7 | 1 |
| Derivative asset, not subject to master netting arrangement | 178 | 183 |
| Derivative asset, fair value, amount offset against collateral, not subject to master netting agreement | 178 | 183 |
| Other the Counter - Cleared | ||
| Offsetting Assets [Line Items] | ||
| Gross amount of recognized derivative assets | 8 | 3 |
| Gross amount of liabilities offset in balance sheet | 0 | 0 |
| Net amount of derivative assets presented in balance sheet | 8 | 3 |
| Financial instruments, amount not offset | 0 | 0 |
| Derivative, collateral, obligation to return securities | 0 | 0 |
| Derivative, collateral, obligation to return cash | (1) | (3) |
| Derivative asset, fair value, amount offset against collateral, subject to master netting agreement | 7 | 0 |
| Securities Lending and Similar Arrangements | ||
| Offsetting Assets [Line Items] | ||
| Gross amounts of recognized financial instruments | 1,959 | 1,029 |
| Gross amounts offset in balance sheet | 0 | 0 |
| Net amounts of assets presented in balance sheet | 1,959 | 1,029 |
| Carrying value of financial instruments not offset in balance sheet | 0 | 0 |
| Securities collateral, not offset in balance sheet | 0 | 0 |
| Cash collateral, not offset in balance sheet | (1,959) | (1,029) |
| Financial instruments, amount of assets offset against collateral | $ 0 | $ 0 |
DERIVATIVE INSTRUMENTS - Offsetting of Financial Liabilities and Derivative Liabilities (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Offsetting Liabilities [Line Items] | ||
| Gross amount of recognized derivative liabilities | $ 257 | $ 285 |
| Gross amount of assets offset in balance sheet | 0 | 0 |
| Derivative liability, fair value, amount not offset against collateral | 257 | 285 |
| Financial instruments, amount not offset | (118) | (152) |
| Derivative, collateral, right to reclaim securities | (65) | (37) |
| Derivative, collateral, right to reclaim cash | (45) | (68) |
| Derivative liability, fair value, amount offset against collateral, subject to master netting agreement | 29 | 28 |
| Derivative liability, not subject to master netting arrangement | 108 | 102 |
| Derivative liability, fair value, amount offset against collateral, not subject to master netting agreement | 108 | 102 |
| Derivative liability, fair value, gross liability including not subject to master netting arrangement | 365 | 387 |
| Net amount of derivative liabilities presented in balance sheet | 365 | 387 |
| Derivative liability, fair value, amount offset against collateral | 137 | 130 |
| Gross Amounts of Recognized Financial Instruments, Offsetting Liabilities | 2,334 | 1,439 |
| Gross Amounts Offset in Statement of Financial Position, Offsetting Liabilities | 0 | 0 |
| Net Amounts of Financial Instruments Presented in Balance Sheet, Offsetting Liabilities | 2,334 | 1,439 |
| Carrying value of financial instruments, liabilities not offset in balance sheet | (2,077) | (1,181) |
| Securities Collateral, Liabilities Not Offset in Balance Sheet | (65) | (37) |
| Cash Collateral, Liabilities Not Offset in Balance Sheet | (45) | (68) |
| Financial instruments, amount of liabilities offset against collateral | 147 | 153 |
| Over the Counter - Bilateral | ||
| Offsetting Liabilities [Line Items] | ||
| Gross amount of recognized derivative liabilities | 257 | 285 |
| Gross amount of assets offset in balance sheet | 0 | 0 |
| Derivative liability, fair value, amount not offset against collateral | 257 | 285 |
| Financial instruments, amount not offset | (118) | (152) |
| Derivative, collateral, right to reclaim securities | (65) | (37) |
| Derivative, collateral, right to reclaim cash | (45) | (68) |
| Derivative liability, fair value, amount offset against collateral, subject to master netting agreement | 29 | 28 |
| Derivative liability, not subject to master netting arrangement | 108 | 102 |
| Derivative liability, fair value, amount offset against collateral, not subject to master netting agreement | 108 | 102 |
| Securities Lending and Similar Arrangements | ||
| Offsetting Liabilities [Line Items] | ||
| Gross Amounts of Recognized Financial Instruments, Offsetting Liabilities | 1,969 | 1,052 |
| Gross Amounts Offset in Statement of Financial Position, Offsetting Liabilities | 0 | 0 |
| Net Amounts of Financial Instruments Presented in Balance Sheet, Offsetting Liabilities | 1,969 | 1,052 |
| Carrying value of financial instruments, liabilities not offset in balance sheet | (1,959) | (1,029) |
| Securities Collateral, Liabilities Not Offset in Balance Sheet | 0 | 0 |
| Cash Collateral, Liabilities Not Offset in Balance Sheet | 0 | 0 |
| Financial instruments, amount of liabilities offset against collateral | $ 10 | $ 23 |
FAIR VALUE MEASUREMENTS - Fair Value Hierarchy Levels of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Assets: | ||
| Available for sale, fixed maturity securities | $ 87,924 | $ 82,895 |
| Equity securities | 1,041 | 987 |
| Other investments | 543 | 152 |
| Cash and cash equivalents | 3,892 | 4,337 |
| Asset derivatives | 401 | 417 |
| Total assets | 93,801 | 88,788 |
| Liabilities: | ||
| Liability derivatives | 365 | 387 |
| Total liabilities | 365 | 387 |
| Foreign currency swaps | ||
| Assets: | ||
| Asset derivatives | 274 | 285 |
| Liabilities: | ||
| Liability derivatives | 206 | 234 |
| Foreign currency forwards | ||
| Assets: | ||
| Asset derivatives | 119 | 126 |
| Liabilities: | ||
| Liability derivatives | 156 | 151 |
| Foreign currency options | ||
| Assets: | ||
| Asset derivatives | 3 | |
| Liabilities: | ||
| Liability derivatives | 2 | 1 |
| Interest rate swaps | ||
| Assets: | ||
| Asset derivatives | 8 | 3 |
| Interest rate swaptions | ||
| Liabilities: | ||
| Liability derivatives | 1 | 1 |
| Government and agencies | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 36,249 | 34,342 |
| Municipalities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 1,908 | 1,863 |
| Mortgage- and asset-backed securities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 414 | 339 |
| Public utilities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 6,497 | 7,171 |
| Sovereign and supranational | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 1,154 | 1,260 |
| Banks/financial institutions | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 9,391 | 8,918 |
| Other corporate | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 32,311 | 29,002 |
| Level 1 | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 34,727 | 32,993 |
| Equity securities | 925 | 874 |
| Other investments | 543 | 152 |
| Cash and cash equivalents | 3,892 | 4,337 |
| Asset derivatives | 0 | 0 |
| Total assets | 40,087 | 38,356 |
| Liabilities: | ||
| Total liabilities | 0 | 0 |
| Level 1 | Foreign currency swaps | ||
| Assets: | ||
| Asset derivatives | 0 | 0 |
| Liabilities: | ||
| Liability derivatives | 0 | 0 |
| Level 1 | Foreign currency forwards | ||
| Assets: | ||
| Asset derivatives | 0 | 0 |
| Liabilities: | ||
| Liability derivatives | 0 | 0 |
| Level 1 | Foreign currency options | ||
| Assets: | ||
| Asset derivatives | 0 | |
| Liabilities: | ||
| Liability derivatives | 0 | 0 |
| Level 1 | Interest rate swaps | ||
| Assets: | ||
| Asset derivatives | 0 | 0 |
| Level 1 | Interest rate swaptions | ||
| Liabilities: | ||
| Liability derivatives | 0 | 0 |
| Level 1 | Government and agencies | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 34,727 | 32,993 |
| Level 1 | Municipalities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 1 | Mortgage- and asset-backed securities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 1 | Public utilities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 1 | Sovereign and supranational | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 1 | Banks/financial institutions | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 1 | Other corporate | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 2 | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 52,627 | 49,380 |
| Equity securities | 70 | 67 |
| Other investments | 0 | 0 |
| Cash and cash equivalents | 0 | 0 |
| Asset derivatives | 223 | 235 |
| Total assets | 52,920 | 49,682 |
| Liabilities: | ||
| Total liabilities | 257 | 285 |
| Level 2 | Foreign currency swaps | ||
| Assets: | ||
| Asset derivatives | 96 | 103 |
| Liabilities: | ||
| Liability derivatives | 98 | 132 |
| Level 2 | Foreign currency forwards | ||
| Assets: | ||
| Asset derivatives | 119 | 126 |
| Liabilities: | ||
| Liability derivatives | 156 | 151 |
| Level 2 | Foreign currency options | ||
| Assets: | ||
| Asset derivatives | 3 | |
| Liabilities: | ||
| Liability derivatives | 2 | 1 |
| Level 2 | Interest rate swaps | ||
| Assets: | ||
| Asset derivatives | 8 | 3 |
| Level 2 | Interest rate swaptions | ||
| Liabilities: | ||
| Liability derivatives | 1 | 1 |
| Level 2 | Government and agencies | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 1,522 | 1,349 |
| Level 2 | Municipalities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 1,908 | 1,863 |
| Level 2 | Mortgage- and asset-backed securities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 236 | 162 |
| Level 2 | Public utilities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 6,412 | 7,062 |
| Level 2 | Sovereign and supranational | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 1,154 | 1,260 |
| Level 2 | Banks/financial institutions | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 9,368 | 8,895 |
| Level 2 | Other corporate | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 32,027 | 28,789 |
| Level 3 | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 570 | 522 |
| Equity securities | 46 | 46 |
| Other investments | 0 | 0 |
| Cash and cash equivalents | 0 | 0 |
| Asset derivatives | 178 | 182 |
| Total assets | 794 | 750 |
| Liabilities: | ||
| Total liabilities | 108 | 102 |
| Level 3 | Foreign currency swaps | ||
| Assets: | ||
| Asset derivatives | 178 | 182 |
| Liabilities: | ||
| Liability derivatives | 108 | 102 |
| Level 3 | Foreign currency forwards | ||
| Assets: | ||
| Asset derivatives | 0 | 0 |
| Liabilities: | ||
| Liability derivatives | 0 | 0 |
| Level 3 | Foreign currency options | ||
| Assets: | ||
| Asset derivatives | 0 | |
| Liabilities: | ||
| Liability derivatives | 0 | 0 |
| Level 3 | Interest rate swaps | ||
| Assets: | ||
| Asset derivatives | 0 | 0 |
| Level 3 | Interest rate swaptions | ||
| Liabilities: | ||
| Liability derivatives | 0 | 0 |
| Level 3 | Government and agencies | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 3 | Municipalities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 3 | Mortgage- and asset-backed securities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 178 | 177 |
| Level 3 | Public utilities | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 85 | 109 |
| Level 3 | Sovereign and supranational | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Level 3 | Banks/financial institutions | ||
| Assets: | ||
| Available for sale, fixed maturity securities | 23 | 23 |
| Level 3 | Other corporate | ||
| Assets: | ||
| Available for sale, fixed maturity securities | $ 284 | $ 213 |
FAIR VALUE MEASUREMENTS - Fair Value Hierarchy Levels of Assets and Liabilities Carried at Cost or Amortized Cost (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
||||||
|---|---|---|---|---|---|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||
| Other investments | $ 1,238 | $ 787 | ||||||
| Assets: | ||||||||
| Securities held to maturity, fixed maturities, amortized cost | 30,163 | 30,318 | ||||||
| Held to maturity, fixed maturity securities, fair value | 37,446 | 36,722 | ||||||
| Commercial mortgage and other loans | 7,180 | 6,919 | ||||||
| Commercial mortgage and other loans, fair value | 7,185 | 6,893 | ||||||
| Other investments carried at amortized cost | 25 | [1] | 26 | [2] | ||||
| Other investments carried at amortized cost, fair value | 25 | [1] | 26 | [2] | ||||
| Total financial instruments assets not carried at fair value | 37,368 | 37,263 | ||||||
| Assets fair value disclosure financial instruments carried at cost | 44,656 | 43,641 | ||||||
| Liabilities: | ||||||||
| Other policyholders’ funds | 7,185 | 7,146 | ||||||
| Other policyholders' funds fair value disclosure | 7,110 | 7,067 | ||||||
| Notes payable | 5,766 | 5,765 | ||||||
| Notes payable, fair value disclosure | 6,079 | 5,876 | ||||||
| Total financial instrument liabilities not carried at fair value | 12,951 | 12,911 | ||||||
| Liabilities fair value disclosure financial instruments carried at cost | 13,189 | 12,943 | ||||||
| Government and agencies | ||||||||
| Assets: | ||||||||
| Securities held to maturity, fixed maturities, amortized cost | 21,961 | 21,712 | ||||||
| Held to maturity, fixed maturity securities, fair value | 27,979 | 27,038 | ||||||
| Municipalities | ||||||||
| Assets: | ||||||||
| Securities held to maturity, fixed maturities, amortized cost | 814 | 359 | ||||||
| Held to maturity, fixed maturity securities, fair value | 1,061 | 469 | ||||||
| Mortgage- and asset-backed securities | ||||||||
| Assets: | ||||||||
| Securities held to maturity, fixed maturities, amortized cost | 20 | 14 | ||||||
| Held to maturity, fixed maturity securities, fair value | 21 | 15 | ||||||
| Public utilities | ||||||||
| Assets: | ||||||||
| Securities held to maturity, fixed maturities, amortized cost | 2,728 | 2,727 | ||||||
| Held to maturity, fixed maturity securities, fair value | 3,068 | 2,973 | ||||||
| Sovereign and supranational | ||||||||
| Assets: | ||||||||
| Securities held to maturity, fixed maturities, amortized cost | 1,154 | 1,551 | ||||||
| Held to maturity, fixed maturity securities, fair value | 1,332 | 1,840 | ||||||
| Banks/financial institutions | ||||||||
| Assets: | ||||||||
| Securities held to maturity, fixed maturities, amortized cost | 949 | 1,445 | ||||||
| Held to maturity, fixed maturity securities, fair value | 1,039 | 1,583 | ||||||
| Other corporate | ||||||||
| Assets: | ||||||||
| Securities held to maturity, fixed maturities, amortized cost | 2,537 | 2,510 | ||||||
| Held to maturity, fixed maturity securities, fair value | 2,946 | 2,804 | ||||||
| Policy loans | ||||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||
| Other investments | 236 | 232 | ||||||
| Equity method investments | ||||||||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||||||||
| Other investments | 434 | 377 | ||||||
| Level 1 | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 27,629 | 27,030 | ||||||
| Commercial mortgage and other loans, fair value | 0 | 0 | ||||||
| Other investments carried at amortized cost, fair value | 0 | [1] | 0 | [2] | ||||
| Assets fair value disclosure financial instruments carried at cost | 27,629 | 27,030 | ||||||
| Liabilities: | ||||||||
| Other policyholders' funds fair value disclosure | 0 | 0 | ||||||
| Notes payable, fair value disclosure | 0 | 0 | ||||||
| Liabilities fair value disclosure financial instruments carried at cost | 0 | 0 | ||||||
| Level 1 | Government and agencies | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 27,629 | 27,030 | ||||||
| Level 1 | Municipalities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 1 | Mortgage- and asset-backed securities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 1 | Public utilities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 1 | Sovereign and supranational | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 1 | Banks/financial institutions | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 1 | Other corporate | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 2 | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 9,804 | 9,677 | ||||||
| Commercial mortgage and other loans, fair value | 0 | 0 | ||||||
| Other investments carried at amortized cost, fair value | 25 | [1] | 26 | [2] | ||||
| Assets fair value disclosure financial instruments carried at cost | 9,829 | 9,703 | ||||||
| Liabilities: | ||||||||
| Other policyholders' funds fair value disclosure | 0 | 0 | ||||||
| Notes payable, fair value disclosure | 5,809 | 5,606 | ||||||
| Liabilities fair value disclosure financial instruments carried at cost | 5,809 | 5,606 | ||||||
| Level 2 | Government and agencies | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 350 | 8 | ||||||
| Level 2 | Municipalities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 1,061 | 469 | ||||||
| Level 2 | Mortgage- and asset-backed securities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 8 | 0 | ||||||
| Level 2 | Public utilities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 3,068 | 2,973 | ||||||
| Level 2 | Sovereign and supranational | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 1,332 | 1,840 | ||||||
| Level 2 | Banks/financial institutions | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 1,039 | 1,583 | ||||||
| Level 2 | Other corporate | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 2,946 | 2,804 | ||||||
| Level 3 | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 13 | 15 | ||||||
| Commercial mortgage and other loans, fair value | 7,185 | 6,893 | ||||||
| Other investments carried at amortized cost, fair value | 0 | [1] | 0 | [2] | ||||
| Assets fair value disclosure financial instruments carried at cost | 7,198 | 6,908 | ||||||
| Liabilities: | ||||||||
| Other policyholders' funds fair value disclosure | 7,110 | 7,067 | ||||||
| Notes payable, fair value disclosure | 270 | 270 | ||||||
| Liabilities fair value disclosure financial instruments carried at cost | 7,380 | 7,337 | ||||||
| Level 3 | Government and agencies | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 3 | Municipalities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 3 | Mortgage- and asset-backed securities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 13 | 15 | ||||||
| Level 3 | Public utilities | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 3 | Sovereign and supranational | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 3 | Banks/financial institutions | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 | ||||||
| Level 3 | Other corporate | ||||||||
| Assets: | ||||||||
| Held to maturity, fixed maturity securities, fair value | $ 0 | $ 0 | ||||||
| ||||||||
FAIR VALUE MEASUREMENTS - Fair Value Hierarchy Levels of Assets by Pricing Source, Securities Carried at Fair Value (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | $ 87,924 | $ 82,895 |
| Equity securities | 1,041 | 987 |
| Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 34,727 | 32,993 |
| Equity securities | 925 | 874 |
| Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 52,627 | 49,380 |
| Equity securities | 70 | 67 |
| Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 570 | 522 |
| Equity securities | 46 | 46 |
| Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity securities | 995 | 941 |
| Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity securities | 925 | 874 |
| Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity securities | 70 | 67 |
| Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity securities | 0 | 0 |
| Net asset value valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity securities | 46 | 46 |
| Net asset value valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity securities | 0 | 0 |
| Net asset value valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity securities | 0 | 0 |
| Net asset value valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Equity securities | 46 | 46 |
| Government and agencies | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 36,249 | 34,342 |
| Government and agencies | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 34,727 | 32,993 |
| Government and agencies | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,522 | 1,349 |
| Government and agencies | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Government and agencies | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 36,249 | 34,342 |
| Government and agencies | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 34,727 | 32,993 |
| Government and agencies | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,522 | 1,349 |
| Government and agencies | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Municipalities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,908 | 1,863 |
| Municipalities | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Municipalities | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,908 | 1,863 |
| Municipalities | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Municipalities | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,908 | 1,863 |
| Municipalities | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Municipalities | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,908 | 1,863 |
| Municipalities | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Mortgage- and asset-backed securities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 414 | 339 |
| Mortgage- and asset-backed securities | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Mortgage- and asset-backed securities | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 236 | 162 |
| Mortgage- and asset-backed securities | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 178 | 177 |
| Mortgage- and asset-backed securities | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 236 | 162 |
| Mortgage- and asset-backed securities | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Mortgage- and asset-backed securities | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 236 | 162 |
| Mortgage- and asset-backed securities | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 178 | 177 |
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 178 | 177 |
| Public utilities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 6,497 | 7,171 |
| Public utilities | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Public utilities | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 6,412 | 7,062 |
| Public utilities | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 85 | 109 |
| Public utilities | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 6,412 | 7,062 |
| Public utilities | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Public utilities | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 6,412 | 7,062 |
| Public utilities | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Public utilities | Discounted cash flow technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 85 | 109 |
| Public utilities | Discounted cash flow technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Public utilities | Discounted cash flow technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Public utilities | Discounted cash flow technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 85 | 109 |
| Sovereign and supranational | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,154 | 1,260 |
| Sovereign and supranational | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Sovereign and supranational | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,154 | 1,260 |
| Sovereign and supranational | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Sovereign and supranational | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,154 | 1,260 |
| Sovereign and supranational | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Sovereign and supranational | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 1,154 | 1,260 |
| Sovereign and supranational | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Banks/financial institutions | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 9,391 | 8,918 |
| Banks/financial institutions | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Banks/financial institutions | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 9,368 | 8,895 |
| Banks/financial institutions | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 23 | 23 |
| Banks/financial institutions | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 9,323 | 8,895 |
| Banks/financial institutions | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Banks/financial institutions | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 9,323 | 8,895 |
| Banks/financial institutions | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Banks/financial institutions | Consensus pricing valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 68 | 23 |
| Banks/financial institutions | Consensus pricing valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Banks/financial institutions | Consensus pricing valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 45 | 0 |
| Banks/financial institutions | Consensus pricing valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 23 | 23 |
| Other corporate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 32,311 | 29,002 |
| Other corporate | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Other corporate | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 32,027 | 28,789 |
| Other corporate | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 284 | 213 |
| Other corporate | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 31,964 | 28,789 |
| Other corporate | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Other corporate | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 31,964 | 28,789 |
| Other corporate | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Other corporate | Discounted cash flow technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 347 | 213 |
| Other corporate | Discounted cash flow technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 0 | 0 |
| Other corporate | Discounted cash flow technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | 63 | 0 |
| Other corporate | Discounted cash flow technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Available for sale, fixed maturity securities | $ 284 | $ 213 |
FAIR VALUE MEASUREMENTS - Fair Value Hierarchy Levels of Assets by Pricing Source, Securities Carried at Amortized Cost (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|---|---|---|
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | $ 37,446 | $ 36,722 |
| Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 27,629 | 27,030 |
| Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 9,804 | 9,677 |
| Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 13 | 15 |
| Government and agencies | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 27,979 | 27,038 |
| Government and agencies | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 27,629 | 27,030 |
| Government and agencies | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 350 | 8 |
| Government and agencies | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Government and agencies | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 27,979 | 27,038 |
| Government and agencies | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 27,629 | 27,030 |
| Government and agencies | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 350 | 8 |
| Government and agencies | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Municipalities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,061 | 469 |
| Municipalities | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Municipalities | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,061 | 469 |
| Municipalities | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Municipalities | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,061 | 469 |
| Municipalities | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Municipalities | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,061 | 469 |
| Municipalities | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Mortgage- and asset-backed securities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 21 | 15 |
| Mortgage- and asset-backed securities | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Mortgage- and asset-backed securities | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 8 | 0 |
| Mortgage- and asset-backed securities | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 13 | 15 |
| Mortgage- and asset-backed securities | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 8 | |
| Mortgage- and asset-backed securities | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | |
| Mortgage- and asset-backed securities | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 8 | |
| Mortgage- and asset-backed securities | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | |
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 13 | 15 |
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 13 | 15 |
| Public utilities | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 3,068 | 2,973 |
| Public utilities | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Public utilities | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 3,068 | 2,973 |
| Public utilities | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Public utilities | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 3,068 | 2,973 |
| Public utilities | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Public utilities | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 3,068 | 2,973 |
| Public utilities | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Sovereign and supranational | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,332 | 1,840 |
| Sovereign and supranational | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Sovereign and supranational | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,332 | 1,840 |
| Sovereign and supranational | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Sovereign and supranational | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,332 | 1,840 |
| Sovereign and supranational | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Sovereign and supranational | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,332 | 1,840 |
| Sovereign and supranational | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Banks/financial institutions | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,039 | 1,583 |
| Banks/financial institutions | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Banks/financial institutions | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,039 | 1,583 |
| Banks/financial institutions | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Banks/financial institutions | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,039 | 1,583 |
| Banks/financial institutions | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Banks/financial institutions | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 1,039 | 1,583 |
| Banks/financial institutions | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Other corporate | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 2,946 | 2,804 |
| Other corporate | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Other corporate | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 2,946 | 2,804 |
| Other corporate | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Other corporate | Third party pricing vendor valuation technique | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 2,946 | 2,804 |
| Other corporate | Third party pricing vendor valuation technique | Level 1 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 0 | 0 |
| Other corporate | Third party pricing vendor valuation technique | Level 2 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | 2,946 | 2,804 |
| Other corporate | Third party pricing vendor valuation technique | Level 3 | ||
| Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] | ||
| Held to maturity, fixed maturity securities, fair value | $ 0 | $ 0 |
FAIR VALUE MEASUREMENTS - Changes in Investments and Derivatives Carried at Fair Value Classified as Level 3 (Detail) - USD ($) $ in Millions |
3 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||||||
| Balance, beginning of period | $ 648 | $ 453 | ||||||||
| Realized investment gains (losses) included in earnings | (8) | 126 | ||||||||
| Unrealized gains (losses) included in other comprehensive income (loss) | 1 | 13 | ||||||||
| Purchases | 63 | 16 | ||||||||
| Issuances | 0 | 0 | ||||||||
| Sales | (2) | 0 | ||||||||
| Settlements | 0 | (1) | ||||||||
| Transfers into Level 3 | 25 | 0 | ||||||||
| Transfers out of Level 3 | (41) | 0 | ||||||||
| Balance, end of period | 686 | 607 | ||||||||
| Change in unrealized gains (losses) still held | (8) | 126 | ||||||||
| Foreign currency swaps | ||||||||||
| Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | ||||||||||
| Balance, beginning of period | [1] | 80 | 22 | |||||||
| Realized gains or losses included in earnings | [1] | (8) | 126 | |||||||
| Unrealized gains or losses included in other comprehensive income (loss) | [1] | (2) | 6 | |||||||
| Purchases | [1] | 0 | 0 | |||||||
| Issuances | [1] | 0 | 0 | |||||||
| Sales | [1] | 0 | 0 | |||||||
| Settlements | [1] | 0 | 0 | |||||||
| Transfers into Level 3 | [1] | 0 | 0 | |||||||
| Transfers out of Level 3 | [1] | 0 | 0 | |||||||
| Balance, end of period | [1] | 70 | 154 | |||||||
| Changes in unrealized gain (losses) still held | [1] | (8) | 126 | |||||||
| Credit default swaps | ||||||||||
| Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] | ||||||||||
| Balance, beginning of period | [1] | 0 | 1 | |||||||
| Realized gains or losses included in earnings | [1] | 0 | 0 | |||||||
| Unrealized gains or losses included in other comprehensive income (loss) | [1] | 0 | 0 | |||||||
| Purchases | [1] | 0 | 0 | |||||||
| Issuances | [1] | 0 | 0 | |||||||
| Sales | [1] | 0 | 0 | |||||||
| Settlements | [1] | 0 | 0 | |||||||
| Transfers into Level 3 | [1] | 0 | 0 | |||||||
| Transfers out of Level 3 | [1] | 0 | 0 | |||||||
| Balance, end of period | [1] | 0 | 1 | |||||||
| Changes in unrealized gain (losses) still held | [1] | 0 | 0 | |||||||
| Fixed maturity securities | Mortgage- and asset-backed securities | ||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||||||
| Balance, beginning of period | 177 | 175 | ||||||||
| Realized investment gains (losses) included in earnings | 0 | 0 | ||||||||
| Unrealized gains (losses) included in other comprehensive income (loss) | 1 | 11 | ||||||||
| Purchases | 0 | 0 | ||||||||
| Issuances | 0 | 0 | ||||||||
| Sales | 0 | 0 | ||||||||
| Settlements | 0 | 0 | ||||||||
| Transfers into Level 3 | 0 | 0 | ||||||||
| Transfers out of Level 3 | 0 | 0 | ||||||||
| Balance, end of period | 178 | 186 | ||||||||
| Change in unrealized gains (losses) still held | 0 | 0 | ||||||||
| Fixed maturity securities | Public utilities | ||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||||||
| Balance, beginning of period | 109 | 68 | ||||||||
| Realized investment gains (losses) included in earnings | 0 | 0 | ||||||||
| Unrealized gains (losses) included in other comprehensive income (loss) | 1 | (1) | ||||||||
| Purchases | 0 | 16 | ||||||||
| Issuances | 0 | 0 | ||||||||
| Sales | 0 | 0 | ||||||||
| Settlements | 0 | 0 | ||||||||
| Transfers into Level 3 | 0 | 0 | ||||||||
| Transfers out of Level 3 | (25) | [2] | 0 | |||||||
| Balance, end of period | 85 | 83 | ||||||||
| Change in unrealized gains (losses) still held | 0 | 0 | ||||||||
| Fixed maturity securities | Banks/financial institutions | ||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||||||
| Balance, beginning of period | 23 | 25 | ||||||||
| Realized investment gains (losses) included in earnings | 0 | 0 | ||||||||
| Unrealized gains (losses) included in other comprehensive income (loss) | 0 | (1) | ||||||||
| Purchases | 0 | 0 | ||||||||
| Issuances | 0 | 0 | ||||||||
| Sales | 0 | 0 | ||||||||
| Settlements | 0 | 0 | ||||||||
| Transfers into Level 3 | 0 | 0 | ||||||||
| Transfers out of Level 3 | 0 | 0 | ||||||||
| Balance, end of period | 23 | 24 | ||||||||
| Change in unrealized gains (losses) still held | 0 | 0 | ||||||||
| Fixed maturity securities | Other corporate | ||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||||||
| Balance, beginning of period | 213 | 146 | ||||||||
| Realized investment gains (losses) included in earnings | 0 | 0 | ||||||||
| Unrealized gains (losses) included in other comprehensive income (loss) | 1 | (2) | ||||||||
| Purchases | 63 | 0 | ||||||||
| Issuances | 0 | 0 | ||||||||
| Sales | (2) | 0 | ||||||||
| Settlements | 0 | (1) | ||||||||
| Transfers into Level 3 | 25 | [2] | 0 | |||||||
| Transfers out of Level 3 | (16) | [3] | 0 | |||||||
| Balance, end of period | 284 | 143 | ||||||||
| Change in unrealized gains (losses) still held | 0 | 0 | ||||||||
| Equity securities | ||||||||||
| Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] | ||||||||||
| Balance, beginning of period | 46 | 16 | ||||||||
| Realized investment gains (losses) included in earnings | 0 | 0 | ||||||||
| Unrealized gains (losses) included in other comprehensive income (loss) | 0 | 0 | ||||||||
| Purchases | 0 | 0 | ||||||||
| Issuances | 0 | 0 | ||||||||
| Sales | 0 | 0 | ||||||||
| Settlements | 0 | 0 | ||||||||
| Transfers into Level 3 | 0 | 0 | ||||||||
| Transfers out of Level 3 | 0 | 0 | ||||||||
| Balance, end of period | 46 | 16 | ||||||||
| Change in unrealized gains (losses) still held | $ 0 | $ 0 | ||||||||
| ||||||||||
FAIR VALUE MEASUREMENTS - Fair Value Measurement Inputs and Valuation Techniques (Details) $ in Millions |
Mar. 31, 2019
USD ($)
|
Dec. 31, 2018
USD ($)
|
|||||
|---|---|---|---|---|---|---|---|
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | $ 87,924 | $ 82,895 | |||||
| Equity securities | 1,041 | 987 | |||||
| Asset derivatives | 401 | 417 | |||||
| Liability derivatives | 365 | 387 | |||||
| Assets, fair value | 93,801 | 88,788 | |||||
| Liabilities, fair value | 365 | 387 | |||||
| Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 570 | 522 | |||||
| Equity securities | 46 | 46 | |||||
| Asset derivatives | 178 | 182 | |||||
| Assets, fair value | 794 | 750 | |||||
| Liabilities, fair value | 108 | 102 | |||||
| Net asset value valuation technique | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Equity securities | 46 | 46 | |||||
| Net asset value valuation technique | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Equity securities | 46 | 46 | |||||
| Foreign currency swaps | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Asset derivatives | 274 | 285 | |||||
| Liability derivatives | 206 | 234 | |||||
| Foreign currency swaps | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Asset derivatives | 178 | 182 | |||||
| Liability derivatives | 108 | 102 | |||||
| Foreign currency swaps | Fair Value, Unobservable Input, Interest Rates (USD), Interest Rates (JPY) and CDS Spreads | Discounted cash flow technique | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Asset derivatives | 117 | 125 | |||||
| Liability derivatives | 102 | 98 | |||||
| Foreign currency swaps | Fair Value, Unobservable Input, Interest Rates (USD) and Interest Rates (JPY) | Discounted cash flow technique | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Asset derivatives | 61 | 57 | |||||
| Liability derivatives | $ 6 | $ 4 | |||||
| Foreign currency swaps | Credit Spread | Fair Value, Unobservable Input, Interest Rates (USD), Interest Rates (JPY) and CDS Spreads | Lower Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | 0.0013 | 0.0019 | |||||
| Derivative liability, measurement input | 0.0030 | 0.0028 | |||||
| Foreign currency swaps | Credit Spread | Fair Value, Unobservable Input, Interest Rates (USD), Interest Rates (JPY) and CDS Spreads | Upper Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | 0.0109 | 0.0120 | |||||
| Derivative liability, measurement input | 0.0187 | 0.0211 | |||||
| Dollar-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | $ 36,076 | $ 33,995 | |||||
| Equity securities | $ 379 | $ 346 | |||||
| Dollar-denominated | Foreign currency swaps | Discount Rate | Fair Value, Unobservable Input, Interest Rates (USD), Interest Rates (JPY) and CDS Spreads | Lower Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | [1] | 0.0248 | 0.0275 | ||||
| Derivative liability, measurement input | [1] | 0.0248 | 0.0275 | ||||
| Dollar-denominated | Foreign currency swaps | Discount Rate | Fair Value, Unobservable Input, Interest Rates (USD), Interest Rates (JPY) and CDS Spreads | Upper Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | [1] | 0.0266 | 0.0284 | ||||
| Derivative liability, measurement input | [1] | 0.0266 | 0.0284 | ||||
| Dollar-denominated | Foreign currency swaps | Discount Rate | Fair Value, Unobservable Input, Interest Rates (USD) and Interest Rates (JPY) | Lower Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | [1] | 0.0248 | 0.0275 | ||||
| Derivative liability, measurement input | [1] | 0.0248 | 0.0275 | ||||
| Dollar-denominated | Foreign currency swaps | Discount Rate | Fair Value, Unobservable Input, Interest Rates (USD) and Interest Rates (JPY) | Upper Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | [1] | 0.0266 | 0.0284 | ||||
| Derivative liability, measurement input | [1] | 0.0266 | 0.0284 | ||||
| Yen-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | $ 51,848 | $ 48,900 | |||||
| Equity securities | $ 662 | $ 641 | |||||
| Yen-denominated | Foreign currency swaps | Discount Rate | Fair Value, Unobservable Input, Interest Rates (USD), Interest Rates (JPY) and CDS Spreads | Lower Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | [2] | 0.0013 | 0.0018 | ||||
| Derivative liability, measurement input | [2] | 0.0013 | 0.0018 | ||||
| Yen-denominated | Foreign currency swaps | Discount Rate | Fair Value, Unobservable Input, Interest Rates (USD), Interest Rates (JPY) and CDS Spreads | Upper Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | [2] | 0.0057 | 0.0071 | ||||
| Derivative liability, measurement input | [2] | 0.0057 | 0.0071 | ||||
| Yen-denominated | Foreign currency swaps | Discount Rate | Fair Value, Unobservable Input, Interest Rates (USD) and Interest Rates (JPY) | Lower Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | [2] | 0.0013 | 0.0018 | ||||
| Derivative liability, measurement input | [2] | 0.0013 | 0.0018 | ||||
| Yen-denominated | Foreign currency swaps | Discount Rate | Fair Value, Unobservable Input, Interest Rates (USD) and Interest Rates (JPY) | Upper Limit | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Derivative asset, measurement input | [2] | 0.0057 | 0.0071 | ||||
| Derivative liability, measurement input | [2] | 0.0057 | 0.0071 | ||||
| Mortgage- and asset-backed securities | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | $ 414 | $ 339 | |||||
| Mortgage- and asset-backed securities | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 178 | 177 | |||||
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 178 | 177 | |||||
| Mortgage- and asset-backed securities | Consensus pricing valuation technique | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 178 | 177 | |||||
| Mortgage- and asset-backed securities | Dollar-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 154 | 162 | |||||
| Mortgage- and asset-backed securities | Yen-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 260 | 177 | |||||
| Banks/financial institutions | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 9,391 | 8,918 | |||||
| Banks/financial institutions | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 23 | 23 | |||||
| Banks/financial institutions | Consensus pricing valuation technique | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 68 | 23 | |||||
| Banks/financial institutions | Consensus pricing valuation technique | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 23 | 23 | |||||
| Banks/financial institutions | Dollar-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 3,269 | 3,214 | |||||
| Banks/financial institutions | Yen-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 6,122 | 5,704 | |||||
| Public utilities | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 6,497 | 7,171 | |||||
| Public utilities | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 85 | 109 | |||||
| Public utilities | Discounted cash flow technique | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 85 | 109 | |||||
| Public utilities | Discounted cash flow technique | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 85 | 109 | |||||
| Public utilities | Dollar-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 4,331 | 5,163 | |||||
| Public utilities | Yen-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 2,166 | 2,008 | |||||
| Other corporate | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 32,311 | 29,002 | |||||
| Other corporate | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 284 | 213 | |||||
| Other corporate | Discounted cash flow technique | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 347 | 213 | |||||
| Other corporate | Discounted cash flow technique | Level 3 | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 284 | 213 | |||||
| Other corporate | Dollar-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | 26,464 | 23,545 | |||||
| Other corporate | Yen-denominated | |||||||
| Fair Value Measurement Inputs and Valuation Techniques | |||||||
| Available for sale, fixed maturity securities | $ 5,847 | $ 5,457 | |||||
| |||||||
FAIR VALUE MEASUREMENTS - Additional Information (Detail) - USD ($) $ in Millions |
Mar. 31, 2019 |
Mar. 31, 2018 |
|---|---|---|
| Fair Value Disclosures [Abstract] | ||
| Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | $ 0 | $ 0 |
| Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | $ 0 | $ 0 |
POLICY LIABILITIES - Changes in Liability for Unpaid Policy Claims (Details) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Liability for Unpaid Claims and Claims Expenses | ||
| Net balance, beginning of period | $ 4,584 | |
| Less claims paid during the period on claims incurred during: | ||
| Net balance, end of period | 4,625 | |
| Total liability for unpaid policy claims | 4,625 | $ 4,630 |
| Health insurance | ||
| Liability for Unpaid Claims and Claims Expenses | ||
| Unpaid supplemental health claims, beginning of period | 3,952 | 3,884 |
| Less reinsurance recoverables | 29 | 30 |
| Net balance, beginning of period | 3,923 | 3,854 |
| Add claims incurred during the period related to: | ||
| Current year | 1,825 | 1,842 |
| Prior years | (167) | (192) |
| Total incurred | 1,658 | 1,650 |
| Less claims paid during the period on claims incurred during: | ||
| Current year | 506 | 518 |
| Prior years | 1,137 | 1,116 |
| Total paid | 1,643 | 1,634 |
| Effect of foreign exchange rate changes on unpaid claims | 0 | 142 |
| Net balance, end of period | 3,938 | 4,012 |
| Add reinsurance recoverables | 29 | 31 |
| Total liability for unpaid policy claims | 3,967 | 4,043 |
| Life insurance | ||
| Less claims paid during the period on claims incurred during: | ||
| Total liability for unpaid policy claims | $ 658 | $ 587 |
POLICY LIABILITIES - Additional Information (Details) - Health insurance - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
| Prior years claims and claims adjustment expense | $ (167) | $ (192) |
| Aflac Japan | ||
| Liability for Future Policy Benefit, by Product Segment [Line Items] | ||
| Prior years claims and claims adjustment expense | $ (91) | |
| Percentage of total prior year claims and claims adjustment expense | 54.00% | |
REINSURANCE - Additional Information (Details) $ in Millions, ¥ in Billions |
3 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2019
JPY (¥)
|
Mar. 31, 2019
USD ($)
|
Dec. 31, 2018
USD ($)
|
|
| Effects of Reinsurance [Line Items] | |||
| Percent change in ceded reserves | 0.30% | ||
| Aflac Japan | |||
| Effects of Reinsurance [Line Items] | |||
| Committed reinsurance facility | ¥ | ¥ 110 | ||
| Aflac Japan | Closed Block | |||
| Effects of Reinsurance [Line Items] | |||
| Reinsurance deferred profit liability | $ 1,000 | ||
| Reinsurance recoverable | $ 944 | $ 941 |
REINSURANCE - Effect of Reinsurance on Premiums and Benefits and Claims (Details) - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Effects of Reinsurance [Line Items] | ||
| Direct premium income | $ 4,776 | $ 4,833 |
| Net premium income | 4,691 | 4,745 |
| Direct benefits and claims | 3,041 | 3,119 |
| Benefits and claims, net | 2,967 | 3,042 |
| All other | ||
| Effects of Reinsurance [Line Items] | ||
| Ceded premiums | (15) | (15) |
| Assumed premiums earned | 1 | 2 |
| Ceded benefits and claims | (11) | (12) |
| Aflac Japan | ||
| Effects of Reinsurance [Line Items] | ||
| Net premium income | 3,180 | 3,263 |
| Aflac Japan | Closed Block | ||
| Effects of Reinsurance [Line Items] | ||
| Ceded premiums | (121) | (129) |
| Assumed premiums earned | 50 | 54 |
| Ceded benefits and claims | (111) | (117) |
| Assumed benefits and claims from other companies | 48 | 52 |
| Intercompany eliminations | ||
| Effects of Reinsurance [Line Items] | ||
| Ceded benefits and claims | 10 | 12 |
| Assumed benefits and claims from other companies | $ (10) | $ (12) |
NOTES PAYABLE AND LEASE OBLIGATIONS - Additional Information (Details) $ in Millions |
3 Months Ended |
|---|---|
|
Mar. 31, 2019
USD ($)
| |
| Debt Instrument [Line Items] | |
| Operating lease, cost | $ 14 |
| Operating lease, payments | 14 |
| Lines of credit | |
| Debt Instrument [Line Items] | |
| Debt instrument, debt default, amount | 0 |
| Notes Payable | |
| Debt Instrument [Line Items] | |
| Debt instrument, debt default, amount | $ 0 |
NOTES PAYABLE AND LEASE OBLIGATIONS - Summary of Notes Payable (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
|||
|---|---|---|---|---|---|
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | [1] | $ 5,900 | $ 5,778 | ||
| Finance lease obligations | 12 | 13 | |||
| Operating lease obligations | [1] | 122 | 0 | ||
| 4.00% senior notes due February 2022 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 348 | 348 | |||
| 3.625% senior notes due June 2023 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 698 | 698 | |||
| 3.625% senior notes due November 2024 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 746 | 746 | |||
| 3.25% senior notes due March 2025 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 448 | 447 | |||
| 2.875% senior notes due October 2026 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 297 | 297 | |||
| 6.90% senior notes due December 2039 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 220 | 220 | |||
| 6.45% senior notes due August 2040 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 254 | 254 | |||
| 4.00% senior notes due October 2046 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 394 | 394 | |||
| 4.750% senior notes due January 2049 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 540 | 540 | |||
| .932% senior notes due January 2027 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 538 | 538 | |||
| 1.159% senior notes due October 2030 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 262 | 262 | |||
| 1.488% senior notes due October 2033 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 136 | 136 | |||
| 1.750% senior notes due October 2038 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 79 | 79 | |||
| 2.108% subordinated notes due October 2047 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 536 | 536 | |||
| Yen-denominated loan variable interest rate due September 2021 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | 45 | 45 | |||
| Yen-denominated loan variable interest rate due September 2023 | |||||
| Debt Instrument [Line Items] | |||||
| Notes payable and lease obligations | $ 225 | $ 225 | |||
| |||||
NOTES PAYABLE AND LEASE OBLIGATIONS - Summary of Notes Payable (Parenthetical) (Details) $ in Millions, ¥ in Billions |
Mar. 31, 2019
USD ($)
|
Mar. 31, 2019
JPY (¥)
|
Dec. 31, 2018
JPY (¥)
|
|---|---|---|---|
| 4.00% senior notes due February 2022 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 4.00% | 4.00% | 4.00% |
| Debt instrument, principal amount | $ | $ 350 | ||
| 3.625% senior notes due June 2023 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 3.625% | 3.625% | 3.625% |
| Debt instrument, principal amount | $ | $ 700 | ||
| 3.625% senior notes due November 2024 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 3.625% | 3.625% | 3.625% |
| Debt instrument, principal amount | $ | $ 750 | ||
| 3.25% senior notes due March 2025 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 3.25% | 3.25% | 3.25% |
| Debt instrument, principal amount | $ | $ 450 | ||
| 2.875% senior notes due October 2026 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 2.875% | 2.875% | 2.875% |
| 6.90% senior notes due December 2039 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 6.90% | 6.90% | 6.90% |
| 6.45% senior notes due August 2040 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 6.45% | 6.45% | 6.45% |
| 4.00% senior notes due October 2046 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 4.00% | 4.00% | 4.00% |
| 4.750% senior notes due January 2049 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 4.75% | 4.75% | 4.75% |
| .932% senior notes due January 2027 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 0.932% | 0.932% | 0.932% |
| Debt instrument, principal amount | ¥ 60.0 | ¥ 60.0 | |
| 1.159% senior notes due October 2030 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 1.159% | 1.159% | 1.159% |
| Debt instrument, principal amount | ¥ 29.3 | ¥ 29.3 | |
| 1.488% senior notes due October 2033 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 1.488% | 1.488% | 1.488% |
| Debt instrument, principal amount | ¥ 15.2 | ¥ 15.2 | |
| 1.750% senior notes due October 2038 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 1.75% | 1.75% | 1.75% |
| Debt instrument, principal amount | ¥ 8.9 | ¥ 8.9 | |
| 2.108% subordinated notes due October 2047 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 2.108% | 2.108% | 2.108% |
| Debt instrument, principal amount | ¥ 60.0 | ¥ 60.0 | |
| Yen-denominated loan variable interest rate due September 2021 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 0.32% | 0.32% | 0.32% |
| Debt instrument, principal amount | ¥ 5.0 | ¥ 5.0 | |
| Yen-denominated loan variable interest rate due September 2023 | |||
| Debt Instrument [Line Items] | |||
| Debt instrument, interest rate | 0.47% | 0.47% | 0.47% |
| Debt instrument, principal amount | ¥ 25.0 | ¥ 25.0 |
NOTES PAYABLE AND LEASE OBLIGATIONS - Contractual Maturities of Leases (Details) - USD ($) $ in Millions |
Mar. 31, 2019 |
Dec. 31, 2018 |
||
|---|---|---|---|---|
| Operating Leases | ||||
| 2019 | $ 33 | |||
| 2020 | 30 | |||
| 2021 | 20 | |||
| 2022 | 17 | |||
| 2023 | 9 | |||
| After 2023 | 24 | |||
| Total lease payments | 133 | |||
| Less: Interest | 11 | |||
| Present value of lease liabilities | [1] | 122 | $ 0 | |
| Finance Leases | ||||
| 2019 | 3 | |||
| 2020 | 3 | |||
| 2021 | 2 | |||
| 2022 | 2 | |||
| 2023 | 1 | |||
| After 2023 | 1 | |||
| Total lease payments | 12 | |||
| Less: Interest | 0 | |||
| Present value of lease liabilities | 12 | $ 13 | ||
| Total | ||||
| 2019 | 36 | |||
| 2020 | 33 | |||
| 2021 | 22 | |||
| 2022 | 19 | |||
| 2023 | 10 | |||
| After 2023 | 25 | |||
| Total lease payments | 145 | |||
| Less: Interest | 11 | |||
| Present value of lease liabilities | $ 134 | |||
| ||||
NOTES PAYABLE AND LEASE OBLIGATIONS - Weighted Average Lease Term and Discount Rate (Details) |
Mar. 31, 2019 |
|---|---|
| Debt Disclosure [Abstract] | |
| Operating lease, weighted average remaining lease term | 4 years 4 months 24 days |
| Finance lease, weighted average remaining lease term | 3 years 9 months 18 days |
| Operating lease, weighted average discount rate, percent | 2.55% |
| Finance lease, weighted average discount rate, percent | 1.56% |
NOTES PAYABLE AND LEASE OBLIGATIONS - Summary of Lines of Credit (Details) - 3 months ended Mar. 31, 2019 ¥ in Millions, $ in Millions |
USD ($) |
JPY (¥) |
|---|---|---|
| $100 million line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, interest rate description | The rate quoted by the bank and agreed upon at the time of borrowing | |
| Line of credit facility term | 364 days | |
| Line of credit facility, maximum borrowing capacity | $ | $ 100 | |
| Line of credit facility, amount outstanding | $ | $ 0 | |
| 100.0 billion yen line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, interest rate description | A rate per annum equal to (a) Tokyo interbank market rate (TIBOR) plus, the alternative applicable TIBOR margin during the availability period from the closing date to the commitment termination date or (b) the TIBOR rate offered by the agent to major banks in yen for the applicable period plus, the applicable alternative TIBOR margin during the term out period | |
| Line of credit facility term | 5 years | |
| Line of credit facility, maximum borrowing capacity | ¥ | ¥ 100,000 | |
| Line of credit facility, amount outstanding | ¥ | 0 | |
| 55.0 billion yen line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, interest rate description | A rate per annum equal to, at the Company's option, either, (a) London Interbank Offered Rate (LIBOR) adjusted for certain costs or (b) a base rate determined by reference to the highest of (1) the federal funds rate plus 1/2 of 1%, (2) the rate of interest for such day announced by Mizuho Bank, Ltd. as its prime rate, or (3) the eurocurrency rate for an interest period of one month plus 1.00%, in each case plus an applicable margin | |
| Line of credit facility term | 5 years | |
| Line of credit facility, maximum borrowing capacity | ¥ | 55,000 | |
| Line of credit facility, amount outstanding | ¥ | 0 | |
| $50 million line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, interest rate description | A rate per annum equal to, at the Parent Company's option, either (a) a eurocurrency rate determined by reference to the agent's LIBOR for the interest period relevant to such borrowing or (b) the base rate determined by reference to the greater of (i) the prime rate as determined by the agent, and (ii) the sum of 0.50% and the federal funds rate for such day | |
| Line of credit facility, maximum borrowing capacity | $ | $ 50 | |
| Line of credit facility, amount outstanding | $ | $ 0 | |
| $250 million line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, interest rate description | USD three-month LIBOR plus 75 basis points per annum | |
| Line of credit facility term | 364 days | |
| Line of credit facility, maximum borrowing capacity | $ | $ 250 | |
| Line of credit facility, amount outstanding | $ | $ 0 | |
| Debt instrument, term | 3 months | |
| 50.0 billion yen line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, interest rate description | Three-month TIBOR plus 80 basis points per annum | |
| Line of credit facility term | 364 days | |
| Line of credit facility, maximum borrowing capacity | ¥ | 50,000 | |
| Line of credit facility, amount outstanding | ¥ | ¥ 0 | |
| Debt instrument, term | 3 months | |
| Lower Limit | 100.0 billion yen line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, commitment fee percentage | 0.30% | |
| Lower Limit | 55.0 billion yen line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, commitment fee percentage | 0.085% | |
| Upper Limit | $100 million line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Debt instrument, term | 3 months | |
| Upper Limit | 100.0 billion yen line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, commitment fee percentage | 0.50% | |
| Upper Limit | 55.0 billion yen line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Line of credit facility, commitment fee percentage | 0.225% | |
| Upper Limit | $50 million line of credit | ||
| Line of Credit Facility [Line Items] | ||
| Debt instrument, term | 3 months |
SHAREHOLDERS' EQUITY - Reconciliation of Number of Shares of Common Stock (Detail) - shares shares in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Common Stock Issued [Roll Forward] | ||
| Balance, beginning of period | 1,347,540 | 1,345,762 |
| Exercise of stock options and issuance of restricted shares | 1,060 | 1,014 |
| Balance, end of period | 1,348,600 | 1,346,776 |
| Treasury Stock [Roll Forward] | ||
| Balance, beginning of period | 592,254 | 564,852 |
| Balance, end of period | 602,113 | 571,019 |
| Shares outstanding, end of period | 746,487 | 775,757 |
| Treasury Stock | ||
| Treasury Stock [Roll Forward] | ||
| Stock acquired in open market, shares | 10,237 | 6,640 |
| Other purchases | 561 | 315 |
| Shares issued to AFL Stock Plan | (430) | (384) |
| Exercise of stock options | (231) | (305) |
| Other dispositions | (278) | (99) |
SHAREHOLDERS' EQUITY - Anti-Dilutive Share-Based Awards Excluded from Calculation of Diluted Earnings Per Share (Detail) - shares shares in Thousands |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Stockholders' Equity Note [Abstract] | ||
| Anti-dilutive share-based awards | 22 | 9 |
SHAREHOLDERS' EQUITY - Additional Information (Detail) - USD ($) shares in Millions, $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Stockholders Equity Note [Line Items] | ||
| Common stock, share repurchase, dollar amount | $ 490 | $ 296 |
| Remaining common stock available for purchase under share repurchase authorizations | 58.8 | |
| Share Repurchase Program | ||
| Stockholders Equity Note [Line Items] | ||
| Stock acquired in open market, shares | 10.2 | 6.6 |
| Common stock, share repurchase, dollar amount | $ 490 | $ 296 |
SHAREHOLDERS' EQUITY - Changes in Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions |
3 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
Dec. 31, 2017 |
|||||||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||
| Cumulative effect of change in accounting principle, net of income taxes | [1] | $ 0 | |||||||
| Accumulated Other Comprehensive Income [Roll Forward] | |||||||||
| Balance, beginning of period | $ 2,151 | $ 4,028 | |||||||
| Other comprehensive income (loss) before reclassifications net of tax | 2,340 | (571) | |||||||
| Amounts reclassified from accumulated other comprehensive income net of tax | (10) | 228 | |||||||
| Other comprehensive income (loss), net of tax | 2,330 | (343) | |||||||
| Balance, end of period | 4,481 | 3,685 | |||||||
| Accumulated other comprehensive income (loss) | |||||||||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||
| Cumulative effect of change in accounting principle, net of income taxes | [1] | $ 226 | |||||||
| Accumulated other comprehensive income (loss) | Accounting Standards Update 2016-01 | |||||||||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||
| Cumulative effect of change in accounting principle, net of income taxes | (148) | ||||||||
| Accumulated other comprehensive income (loss) | Accounting Standards Update 2018-02 | |||||||||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||
| Cumulative effect of change in accounting principle, net of income taxes | 374 | ||||||||
| Unrealized foreign currency translation gains (losses) | |||||||||
| Accumulated Other Comprehensive Income [Roll Forward] | |||||||||
| Balance, beginning of period | (1,847) | (1,750) | |||||||
| Other comprehensive income (loss) before reclassifications net of tax | (1) | 447 | |||||||
| Amounts reclassified from accumulated other comprehensive income net of tax | 0 | 0 | |||||||
| Other comprehensive income (loss), net of tax | (1) | 447 | |||||||
| Balance, end of period | (1,848) | (1,303) | |||||||
| Unrealized gains (losses) on investment securities | |||||||||
| Accumulated Other Comprehensive Income [Roll Forward] | |||||||||
| Balance, beginning of period | 4,234 | 5,964 | |||||||
| Other comprehensive income (loss) before reclassifications net of tax | 2,340 | (983) | |||||||
| Amounts reclassified from accumulated other comprehensive income net of tax | (13) | 225 | [2] | ||||||
| Other comprehensive income (loss), net of tax | 2,327 | (758) | |||||||
| Balance, end of period | 6,561 | 5,206 | |||||||
| Unrealized gains (losses) on derivatives | |||||||||
| Accumulated Other Comprehensive Income [Roll Forward] | |||||||||
| Balance, beginning of period | (24) | (23) | |||||||
| Other comprehensive income (loss) before reclassifications net of tax | (2) | 2 | |||||||
| Amounts reclassified from accumulated other comprehensive income net of tax | 0 | 0 | |||||||
| Other comprehensive income (loss), net of tax | (2) | 2 | |||||||
| Balance, end of period | (26) | (21) | |||||||
| Pension liability adjustment | |||||||||
| Accumulated Other Comprehensive Income [Roll Forward] | |||||||||
| Balance, beginning of period | (212) | (163) | |||||||
| Other comprehensive income (loss) before reclassifications net of tax | 3 | (37) | |||||||
| Amounts reclassified from accumulated other comprehensive income net of tax | 3 | 3 | |||||||
| Other comprehensive income (loss), net of tax | 6 | (34) | |||||||
| Balance, end of period | $ (206) | $ (197) | |||||||
| |||||||||
SHAREHOLDERS' EQUITY - Reclassifications Out of Accumulated Other Comprehensive Income (Details) - USD ($) $ in Millions |
3 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
||||||||||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
| Other-than-temporary impairment losses realized | $ (2) | $ (7) | |||||||||
| Other gains (losses) | 73 | (127) | |||||||||
| Total before tax | 1,242 | 982 | |||||||||
| Income tax (expense) or benefit | (314) | (265) | |||||||||
| Net of tax | $ 928 | $ 717 | |||||||||
| Blended statutory income tax rate | 25.00% | 27.00% | |||||||||
| Reclassification Out Of Accumulated Other Comprehensive Income | |||||||||||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
| Net of tax | $ 10 | $ (2) | |||||||||
| Reclassification Out Of Accumulated Other Comprehensive Income | Unrealized gains (losses) on investment securities | |||||||||||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
| Other-than-temporary impairment losses realized | 0 | 0 | |||||||||
| Other gains (losses) | 17 | 2 | |||||||||
| Total before tax | 17 | 2 | |||||||||
| Income tax (expense) or benefit | (4) | [1] | (1) | [2] | |||||||
| Net of tax | 13 | 1 | |||||||||
| Reclassification Out Of Accumulated Other Comprehensive Income | Pension liability adjustment | |||||||||||
| Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] | |||||||||||
| Acquisition and operating expenses, actuarial gains (losses) | [3] | (4) | (4) | ||||||||
| Acquisition and operating expenses, prior service (cost) credit | [3] | 0 | 0 | ||||||||
| Income tax (expense) or benefit | 1 | [1] | 1 | [2] | |||||||
| Net of tax | $ (3) | $ (3) | |||||||||
| |||||||||||
SHARE-BASED COMPENSATION - Additional Information (Detail) - USD ($) shares in Thousands, $ in Millions |
1 Months Ended | 3 Months Ended | ||
|---|---|---|---|---|
Feb. 28, 2019 |
Mar. 31, 2019 |
Mar. 31, 2018 |
Dec. 31, 2018 |
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
| Proceeds from stock options exercised | $ 17 | $ 23 | ||
| Tax benefit from exercise of stock options | $ 22 | $ 12 | ||
| Long-Term Incentive Plan | ||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
| Share-based compensation arrangement by share-based payment award, maximum number of shares issuable | 75,000 | |||
| Share-based compensation arrangement by share-based payment award, maximum number of shares issuable other than options and stock appreciation rights | 38,000 | |||
| Shares available for future grants under the long-term incentive plan | 39,400 | |||
| Long-term incentive plan awards, term (in years) | 10 years | |||
| Long-term incentive plan awards, vesting period | 3 years | |||
| Restricted Stock | ||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
| Total compensation cost not yet recognized, restricted stock awards | $ 70 | |||
| Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number, shares | 2,597 | 3,407 | ||
| Employee service share-based compensation, nonvested awards, compensation cost not yet recognized, period for recognition | 1 year 4 months 24 days | |||
| Restricted stock awards, grants in period | 940 | |||
| Performance based Vesting Condition | Restricted Stock | ||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ||||
| Total compensation cost not yet recognized, restricted stock awards | $ 33 | |||
| Share-based compensation arrangement by share-based payment award, equity instruments other than options, nonvested, number, shares | 824 | |||
| Restricted stock awards, grants in period | 399 | |||
SHARE-BASED COMPENSATION - Stock Options Outstanding and Exercisable (Detail) $ / shares in Units, shares in Thousands, $ in Millions |
3 Months Ended |
|---|---|
|
Mar. 31, 2019
USD ($)
$ / shares
shares
| |
| Disclosure of Compensation Related Costs, Share-based Payments [Abstract] | |
| Options Outstanding - Stock Option Shares | shares | 4,558 |
| Options Outstanding - Weighted-Average Remaining Term (Yrs) | 5 years |
| Options Outstanding - Aggregate Intrinsic Value | $ | $ 94 |
| Options Outstanding - Weighted-Average Exercise Price Per Share | $ / shares | $ 29.36 |
| Options Exercisable - Stock Option Shares | shares | 4,097 |
| Options Exercisable - Weighted-Average Remaining Term (Yrs.) | 4 years 7 months 6 days |
| Options Exercisable - Aggregate Intrinsic Value | $ | $ 88 |
| Options Exercisable - Weighted-Average Exercise Price Per Share | $ / shares | $ 28.54 |
SHARE-BASED COMPENSATION - Restricted Stock Activity (Details) - Restricted Stock shares in Thousands |
3 Months Ended |
|---|---|
|
Mar. 31, 2019
$ / shares
shares
| |
| Shares | |
| Beginning Balance | shares | 3,407 |
| Granted | shares | 940 |
| Canceled | shares | (18) |
| Vested | shares | (1,732) |
| Ending Balance | shares | 2,597 |
| Weighted-Average Grant-Date Fair Value Per Share | |
| Beginning Balance | $ / shares | $ 36.52 |
| Granted | $ / shares | 49.17 |
| Cancelled | $ / shares | 37.98 |
| Vested | $ / shares | 32.16 |
| Ending Balance | $ / shares | $ 44.02 |
BENEFIT PLANS - Additional Information (Detail) - USD ($) $ in Millions |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
Dec. 31, 2013 |
|
| Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
| Amount of years active employees have left to meet rule of 80 in order to be eligible for postretirement medical benefits | 5 years | ||
| Amount of years left to meet 15 year service requirement for active employees age 55 or older to be eligible for postretirement medical benefits | 5 years | ||
| Net periodic (benefit) cost, excluding service cost | $ 5 | $ 5 | |
| Lower Limit | |||
| Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
| Health care plan, retirement age and years of service combined years for eligibility (rule of 80) | 80 years | ||
| Health care plan, retirement age for eligibility, (in years) | 55 years | ||
| Health care plan, number of years of service for eligibility | 15 years | ||
| Japan | Pension Plan | |||
| Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
| Employer contributions | 9 | ||
| U.S. | Pension Plan | |||
| Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | |||
| Employer contributions | $ 10 | ||
BENEFIT PLANS - Net Periodic (Benefit) Cost Included in Acquisition and Operating Expenses (Detail) - Pension Plan - USD ($) $ in Millions |
3 Months Ended | |
|---|---|---|
Mar. 31, 2019 |
Mar. 31, 2018 |
|
| Japan | ||
| Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
| Service cost | $ 5 | $ 5 |
| Interest cost | 1 | 2 |
| Expected return on plan assets | (2) | (2) |
| Amortization of net actuarial loss | 1 | 0 |
| Net periodic (benefit) cost | 5 | 5 |
| U.S. | ||
| Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items] | ||
| Service cost | 6 | 7 |
| Interest cost | 9 | 9 |
| Expected return on plan assets | (7) | (7) |
| Amortization of net actuarial loss | 3 | 4 |
| Net periodic (benefit) cost | $ 11 | $ 13 |
COMMITMENTS AND CONTINGENT LIABILITIES - Additional Information (Details) $ in Millions, ¥ in Billions |
3 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2019
USD ($)
|
Mar. 31, 2019
JPY (¥)
|
Mar. 31, 2017
USD ($)
|
|
| Commitments And Contingencies Disclosure [Line Items] | |||
| Loss contingency accrual, insurance-related assessment, discount rate | 4.25% | ||
| Loss contingency, discounted amount of insurance-related assessment liability | $ 62 | ||
| Loss contingency, undiscounted amount of insurance-related assessment liability | 94 | ||
| Loss contingency, insurance-related assessment, discounted amount of premium tax offset | 48 | ||
| Loss contingency, insurance-related assessment, undiscounted amount of premium tax offset | 74 | ||
| Loss contingency, loss in period | $ 14 | ||
| Information technology and data services company application maintenance and development services first agreement | |||
| Commitments And Contingencies Disclosure [Line Items] | |||
| Outsourcing agreements, remaining term | 5 years | 5 years | |
| Outsourcing agreements, aggregate remaining cost | $ 87 | ¥ 9.7 | |
SUBSEQUENT EVENTS Additional Information (Detail) - Perpetual subordinated bonds - Subsequent events ¥ in Billions |
Apr. 12, 2019
JPY (¥)
|
|---|---|
| Subsequent Event [Line Items] | |
| Debt instrument, principal amount | ¥ 30.0 |
| Debt instrument, interest rate | 0.963% |
| Debt instrument, description of variable rate basis | These bonds will bear interest at a fixed rate of .963% per annum and then at six-month Euro Yen LIBOR plus an applicable spread on and after the day immediately following April 18, 2024. |